Winter 2012 Minnesota Pharmacist by MPhA Minnesota Pharmacists Association

McKesson Delivers the Industry’s Best Service

So You Can Focus on What Really Matters: Your Patients Success begins with knowing your business. Your McKesson representative will conduct an annual profitability analysis to track your strengths, find new opportunities, and understand your unique business issues. Being your strategic advisor is just the start. With McKesson, you'll get the industry's best service and innovative programs that can help you enhance profitability—from managed care and generics, to automation and best-inclass front-end services. Most important, you'll get a partner committed to promoting your interests so you can focus on providing the personalized care that sets you apart.

Minnesota Pharmacist Winter 2012 n

Call McKesson Calltoday today to to learn learn how how McKesson can canhelp help build build your your independent independent pharmacy’s pharmacy’ssuccess. success. Kim Diemand, Diemand Vice President Sales Kim Vice President-RxOwnership Todd Bender, District Sales Manager NorthCanada Central Distribution Region Little Center 651.484.4811 Todd Bender District Sales Manager Little Canada Distribution Center 651.484.4811

MPhA Board of Directors Executive/Finance Committee: President: Scott Setzepfandt Past-President: Brent Thompson President-Elect: Martin Erickson Secretary-Treasurer: Bill Diers Speaker: Meghan Kelly Executive Vice President: Julie K. Johnson Rural Board Members: Eric Slindee Mark Trumm Metro Board Members: Cheng Lo James Marttila At-Large Board Members: Tiffany Elton Tim Cernohous Amy Sapola Jill Strykowski Jason Varin Student Representation: Duluth MPSA Liaison: Jeremy LeBlanc Minneapolis MPSA Liaison: Kandace Schuft Ex-Officio: Rod Carter, COP Julie K. Johnson, MPhA MSHP Representative Pharmacy Technician Representative: Barb Stodola

MINNESOTA PHARMACIST

Official publication of the Minnesota Pharmacists Association. MPhA is an affiliate of the American Pharmacists Association, the American Society of Consultant Pharmacists, the Academy of Managed Care Pharmacy, and the National Community Pharmacists Association.

Editor: Julie K. Johnson Managing Editor, Design and Production: Anna Wrisky The Minnesota Pharmacist (ISSN # 0026-5616) journal is published quarterly by the Minnesota Pharmacists Association, 1000 Westgate Drive, Suite 252, St. Paul, MN 55114-1469. Phone: 651-697-1771 or 1-800-4518349, 651-290-2266 fax, info@mpha.org. Periodicals postage paid at St. Paul, MN (USPS-352040). Postmaster: Send address changes to Minnesota Pharmacists Association, 1000 Westgate Drive, Suite 252, St. Paul, MN 55114-1469. Article Submission/advertising: For writer’s guidelines, article submission, or advertising opportunities, contact the editor at the above address or email julie@ mpha.org. Bylined articles express the opinion of the contributors and do not necessarily reflect the position of the Minnesota Pharmacists Association. Articles printed in this publication may not be reproduced in any manner, either in whole or in part, without specific written permission of the publisher.

Winter 2012 Volume 66. Number 1, ISSN 0026-5616

in this issue President’s Desk A Valuable Insight: Patients Appreciate Extra Effort. . . . . . . . . . . . . . . . . . . . . . . . . 4 Executive’s Report Remembering the Dream Weaver . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 pharmacy and the law Recordkeeping Isn’t that Important, is it? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 features Walgreens: “America’s Premier Pharmacy” Lives Up to its Self-Image . . . . . . . . . . . 8 Drug Dosing Based on Kidney Function: A Survey of Minnesota Pharmacists. . . . 10 Minnesota Practice-Based Research Network: An Update. . . . . . . . . . . . . . . . . . . . 14 Home Care: A New Frontier for Pharmacy Practice . . . . . . . . . . . . . . . . . . . . . . . . 18 MPhA Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 Committees and Task Forces. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 MPhA Benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 Community Pharmacy Defense Fund. . . . . . . . . . . . . . . . . . . . . 24 Pharmacy Future Fund. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25 MPhA Award Nomination Form . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 Legislative Directory. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 Pharmacy Resources. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 2012 MphA Award Categories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34

Advertisers Dakota Drug Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 McKesson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2, 39 Minnesota Pharmacists Foundation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 MPhA Career Center. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 PACE Alliance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17, 39 Pharmcists Mutual Companies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Pharm PAC. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 Pharmacy Quality Commitment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13

Acceptance of advertisement does not indicate endorsement. Minnesota Pharmacist Winter 2012 n

president’s desk

A Valuable Insight: Patients Appreciate Extra Effort by Scott Setzepfandt, RPh, MPhA President

“Thank you, Tia!”

Get out from behind the counter and ask!

One of the more rewarding aspects of being a community pharmacist is when your patient thanks you for providing good counseling, especially when you aren’t expecting it. Pharmacists are well trained to provide good drug therapy management. They do it every day, and for the most part don’t even think about the valuable service they are providing. It’s a humble bunch of professionals who really don’t expect accolades for doing their job well. On the other hand, there are barriers in place that make it difficult to do just that. A study was reported in the Journal of the American Pharmacist Association last summer that looked at pharmacy services from the patient perspective.1 In that study, more than 90% of those surveyed indicated a desire for pharmacist-provided information or that written material was insufficient when obtaining a new prescription. Even on refills, nearly half surveyed indicated they wanted more information than simply how many refills were left. The study also looked at barriers to getting the information they desired. One might think the obvious barrier is a lack of privacy due to the layout of the pharmacy. Surprisingly, from the patients’ perspective, this came up only 4% of the time. It is reassuring, too, that only 1.5% indicated they did not trust the pharmacist to provide good information. On the other hand, the perception that pharmacists were not “approachable” came up 18.7% of the time. But 63% of the patients reported the largest barrier was the patient him/herself. Reasons cited: lacking time 9.7%, perceiving no need for info 9.7%, lacking initiative 20.0% and fear or embarrassment at 24.2%. The article contains much more data, but suffice to say patients want to interact and receive information from pharmacists — but aren’t motivated or sure how to do so or are restrained by fear or embarrassment to reach out. This is valuable insight. We may want to provide counseling, but how do we reduce the barriers? How do we overcome both the barrier of being perceived as unapproachable as well as self-imposed barriers by the patient? One way is to simply get out from behind the counter and ask. The other day I was getting some groceries and decided to swing by the pharmacy area to see what niacin they had on the shelf. My doctor recently informed me that my HDL/LDL ratio needed

Minnesota Pharmacist Winter 2012 n

improvement; along with increased exercise he recommended I start taking niacin. So there I was, checking out the nutrition shelves looking for it. Out from behind the counter came Tia Paulson, PharmD. She asked me if I needed any help. Always curious about how well pharmacists counsel, I put my patient hat on and played ignorant (some would argue that isn’t a hard task for me…but that’s a whole different article). I told Tia my doctor advised that I start taking niacin daily and asked what the difference was and what she would recommend. She explained the differences of the ones they had in stock, told me about what type of side effect I might experience and recommended when I should take it. It was a short exchange but she answered all of my questions clearly and in a reassuring manner. I put the bottle in my cart and went about finishing the rest of my shopping. As I rolled my cart around the store I reflected on how nice an exchange that was, how interested Tia seemed in my wellbeing, and how useful her information would be for the patient who has no real health care background. I also thought about how rarely the pharmacist is made aware that what they did was very much appreciated. Sure, I gave Tia a typical “thanks,” but it just didn’t seem like enough. So before I left the store I went back to thank Tia. I told her who I was, thanked her again for doing a great job of counseling and asked if it was OK if I mentioned her in my next article for MPhA. She was surprised and blushed a little. But I believe she, as well as all of you who take that extra effort, deserve to know that the patient really does appreciate what you do. So, like Tia, take a step around the counter and make yourself available and approachable. They will appreciate it. I did. Thank you, Tia! 1 “Patient perspective of medication information”, JAPhA, July/Aug 2011, pp510-519.

Dear Pharmacy Colleague, The Minnesota Pharmacists Association is pleased to host the 5th Annual platform/poster presentation program at the MPhA 128th Annual Meeting, Minnesota Research and Practice Innovation Forum being held at Madden’s Resort in Brainerd, Minn. This venture provides an opportunity for those of us performing research or developing innovative pharmacy services to present findings and experience to pharmacy practitioners in Minnesota. It is an exciting opportunity for practicing pharmacists, academic faculty, residents and students to display their work, and to share its impact with the individuals responsible for serving the medication needs of Minnesota’s citizens. In past years we have received excellent examples of innovation and research in pharmacy; and we hope that more pharmacists and students will participate this year. The platform presentation program will be held on Saturday, June 9, 2012, from 10:00 a.m. to 11:00 a.m. as part of the MPhA continuing pharmacy education. The posters will be displayed in the Exhibit Hall from 12:00 noon to 1:30 p.m. immediately following the Oral Abstract presentations. You are strongly invited/encouraged to submit an abstract of your work using the form on page 22. Please indicate if you prefer platform or poster presentation format on the form. The program has capacity for four platform presentations and 24 posters. The selection committee will make the final determination. Authors should plan a 15-minute platform presentation which includes time for questions. Audio-visual equipment will be available [please check the appropriate boxes on the form for audio-visual needs.] Submission deadline is Friday, April 22, 2010. Notification of acceptance and presentation format/time will be sent via email to the address provided on the abstract by May 2, 2011 giving abstract presenters time to prepare posters to display for the Annual Meeting. The Minnesota Research and Practice Innovation Forum abstract form is attached in Word format, or you can go to the Minnesota Pharmacists Association Web site (www.mpha.org) to download the abstract form. If you are unable to access the abstract, we can email, fax, or mail a copy to you. If you have any questions, contact Julie Johnson at the MPhA office at julie@mpha.org or 651-290-7486. Please encourage students and colleagues working on projects with application to any aspect of pharmacy practice/administration/management to submit an abstract for presentation at the Conference.

Upcoming Events Visit www.mpha.org for more information

128th Annual Meeting, June 8-10, 2012 Madden’s Resort, Brainerd HerbIe Cup Golf Invitational, June 8, 2012 Madden’s Resort, Brainerd Pharmacy Technician Conference MSHP/MPhA Event, July 19, 2012 Crowne Plaza, Plymouth FAll Clinical Symposium, September 16, 2012 Crowne Plaza, Plymouth fall mtm symposium, November 16, 2012 DoubleTree Hotel, Bloomington

Sincerely, Scott Setzepfandt, RPh MPhA President

Moved, graduated, or have a name change? Update your profile through your online MPhA Member Portal page.

Minnesota Minnesota Pharmacist Pharmacist Winter Winter 20122012 5 n

executive’s report

Remembering The Dream Weaver by Julie K. Johnson, PharmD, MPhA Executive Vice President/CEO

My classmates at the University of Minnesota Class of 1981 called him “Dream Weaver.” My memory from College of Pharmacy days blurs a little — but here is my perception of that time: Classes were challenging. The curriculum seemed to be forever changing. The question of the day was, “should I go on to get my PharmD?” Did I mention the classes were challenging? The thought (to me) of spending two more years working/studying/ working/studying/taking tests/working did not appeal to me at all. No one could convince me that more education was going to prepare me to land a better job any faster than I would graduating with a BS in pharmacy in 1981 from one of the highest ranked colleges in the country. I had a plan. Graduate, get out, get a job, don’t look back — and for heaven’s sake, don’t go back.

Your dreams live on in all of us, Larry. Thank you for the things you gave to us. You have paid it forward for a very long time.

Julie K. Johnson, PharmD MPhA Executive Vice President/CEO

Does this sound at all familiar to anyone? Do things change as much as they stay the same? Larry Weaver led the growth of the profession of pharmacy throughout his entire life. He pushed to improve curricula, build buildings, and move the College of Pharmacy into the health sciences complex from its original home in riverside Appleby Hall. I did go back, like many of you. Back to the College of Pharmacy to be a preceptor, to be a mentor, to deliver a lecture and to teach classes. I joined the association after graduation because someone made me. I joined the staff of the College on a part-time basis for 12 years. I joined the MPhA in 2001. I returned to complete my PharmD in 2006, long after Larry Weaver “retired.” My perceptions changed as years passed. His effect on me, and everyone he knew, was profound. No one person directly influences one other person all on his or her own. But the tapestry of positive influence created by the lifelong contributions of people like Larry Weaver will forever exist. He dreamed big and never, ever, ever gave up. He was dean in the ‘80s and then again later, when he was needed in that position again. WHAT? Who would do that? Nobody is dean twice. He was present at every pharmacy function I can remember. Big as life with his life partner always at his side. Kind, soft spoken, a small-statured giant. Larry was my dean. I did not know what that meant in the ‘80s. I know now.

Minnesota Pharmacist Winter 2012 n

viewpoint

Walgreens: “America’s premier pharmacy” lives up to its self-image 1

by Lowell J. Anderson, DSc, FAPhA

This is a pat on the back for Walgreens for its public and professional leadership. It is not about Express Scripts (ESI) — ESI is just doing what PBMs normally do. Walgreens has chosen to reject the contract offered by Express Scripts and removed itself from the Express Scripts network by January 1, 2012. I have no idea what the dollars are in the negotiation. It really doesn’t matter to me, because it is not so much the why as it is the how. Walgreens effectively told the world that there was a reimbursement even they could not accept. They have managed to save some contracts because of the relationships and contracts with employers. By the time this is printed they may have even have come to terms with ESI.

with independents, where (in Minnesota) there is a whole generation of pharmacists who have not experienced the thrill of having a PBM increase a dispensing fee. As partial justification for its action, Walgreens cites pharmacy services that are currently not compensated. With growth in prescription-drug sales slowing, Walgreens and other major retail pharmacy chains hope to boost revenue by offering new health-care services. In addition to filling prescriptions, they now help patients manage their medications. For example, Walgreens pharmacists advise customers on appropriate doses and try to switch them to cheaper generic alternatives when possible. “Our product is not a pill; our product is a health outcome,” says Walgreens Chief Executive Greg Wasson.

In the meantime, it will have caused concern or inconvenienced a lot of Walgreens customers. But those several millions might just get a feel for the economic facts of life in the prescription business. The company’s stock is down 30% since they announced the disagreement in June. That is a lot of money — so even the investor community might understand.

Express Scripts’ response thus far: A pill’s a pill, and Walgreens doesn’t deserve more money than other pharmacies for telling patients how to take them. If Express Scripts did agree to pay more, Walgreens would become its most expensive pharmacy, raising client costs “for essentially doing the same thing as everyone else,” says spokesman Brian Henry.2

I know that contrary to conventional wisdom, chains do reject contracts for a variety of reasons. We rarely hear of these rejections because it is good business to keep contract negotiations close. They usually do not broadcast these decisions to either the public or broadly to the profession.

Re-read that Express Script response — it is telling! Mr. Henry’s assertion that “A pill’s a pill” clearly reflects a philosophy that a prescription medication is merely a product that requires distribution. Evidently ESI has little corporate concern about whether or not the “pill” achieves the desired outcome — the outcome that its employer customer is paying for.

Pharmacists in independent practice understand that they have little bargaining clout when it comes to negotiating contracts with pharmacy benefit managers and managed-care organizations. In spite of the often-repeated assertions by these organizations that contracts are negotiated, the independents are usually told to “take it or leave it,” should they try to negotiate. More often than not, to “leave it” is not an option for the independent and smaller chains. The chains, however, may negotiate with some degree of success because the PBMs and MCOs need their distribution channels; and one negotiation may result in several thousand outlets. I suspect that many of the chain/PBM contracts have even kept pace with the rising costs of dispensing even if not fully recovering dispensing costs. Certainly that is not the case 8

Minnesota Pharmacist Winter 2012 n

On the plus side, Mr. Henry does recognize that “everyone else” does provide information. Of course they don’t pay “everyone else” either. I imagine that this was a much-researched decision by Walgreens as there are very real costs and market considerations. I have no doubt that Walgreens assessment was that signing the offered contract would not be a financially responsible and defensible decision. Ultimately, they must answer to the Walgreens’ stockholders. Mr. Wasson, Walgreens CEO, said in an analyst conference call: “The terms Express Scripts offered us, including rates that were below the industry average cost to provide the prescription,

were not in the best interest of our company, our customers, our employees or our shareholders.”3

of our company, our customers, our employees or our shareholders”?

ESI is in a sticky spot here also. If it does agree to a contract with Walgreens that assigns a value for what “everyone does for free” it will provide an opportunity for other pharmacy providers to seek similar treatment that recognizes the value of pharmacists’ services in their next contracts.

Personally, I commend Walgreens for its actions — both for rejecting a contract that was not in its interests or the interests of the customers it serves, and even more important, for bringing the issue to the professional, public and investor communities.

Corporate courage — sometimes hard to distinguish from tough negotiating, but still courage — is a rarely seen attribute today. I think that the pharmacists of America should support the courage of Walgreens. When the Express Script member transfers a prescription because of this contract disagreement, the receiving pharmacist should talk to the member about the importance of compensation for valuable services and compliment Walgreens for its courage. And also how their employer and its PBM have chosen to not pay for these services. The Walgreens pharmacists, I hope, do likewise when their patients ask about the contract. Walgreens, by some estimates, may lose 10% of prescription volume over this. Are the independents and other chains prepared to take a stand with similar costs? Our history is that we do not. And, of course, that is why the fee schedules are what they are. When pharmacy owners and managers read these contracts it should be with the same question that Mr. Wasson addressed: are these contracts “in the best interest

Lowell J. Anderson, D.Sc., FAPhA, practiced in community pharmacy for most of his career. He is a former president of MPhA, Mn Board of Pharmacy and APhA. In addition he has held positions in the Accrediting Council on Pharmacy Education, National Association of Board of Pharmacy and the United States Pharmacopeia. Currently he is Co-director of the Center for Leading Healthcare Change, University of Minnesota and co-editor of the International Pharmacy Journal. He is a Remington Medalist. 1 Walgreens Web site 2 “Walgreens seeks payment for customer counseling in Express Scripts battle”, The Wall Street Journal, 25 October 2011 3 Medill Reports, Shaina Humphries, 15 November 2011

Minnesota Pharmacist Winter 2012 n

feature

Drug dosing based on kidney function:

a survey of minnesota pharmacists By Kenzie G. Hohman, PharmD Candidate, and Wendy St. Peter, PharmD, BCPS, FASN, FCCP

Drug dosage adjustment based on kidney function is a standard of practice in some ambulatory and most acute care settings as impairment of kidney function alters the pharmacokinetics of several medications. Dose modifications based on kidney function are made to improve therapeutic outcomes and minimize adverse effects or toxicity. Direct measurement of the glomerular filtration rate (GFR), using an exogenous marker such as inulin, is the most accurate method to measure kidney function, but is difficult, time-consuming, and expensive.2,12,18 There are several other methods to estimate kidney function and method utilization varies between practitioners.1-3,8,16 This creates a challenge in determining the optimal dosing regimen. To facilitate in the detection of CKD, the National Kidney Disease Education Program (NKDEP) strongly encourages laboratories to routinely report estimated GFR values when serum creatinine values are measured in patients 18 years or older.11 The availability of the eGFR in laboratory reports may result in confusion among health professionals on whether or not to use reported eGFR results to dose medications. Up to this point, there have been no prospective pharmacokinetic studies that have utilized eGFR results to create drug dosing recommendations. The U.S. Food and Drug Administration’s (FDA) guidance document for kidney impairment, published in 1998, recommends that pharmaceutical companies use the Cockcroft-Gault (C-G) equation to estimate kidney function.5 Thus, most medications’ renal drug dosing guidelines have been developed using the C-G equation as the basis for estimating kidney function. A variety of body weights including actual body weight, ideal body weight, adjusted body weight, or lean body weight are utilized for the weight parameter within the C-G equation. Also, for serum creatinine values less than 1 mg/dL, some practitioners may round up to 1 mg/dL, or another value, depending on patient parameters (i.e. weight or age). To add to the clinical conundrum, the NKDEP has recommended that creatinine assay manufacturers incorporate assay calibration standards.10,11 To date, the majority of clinical laboratories are using standardized creatinine assays.11 Creatinine assay calibration

standardization reduces variation of serum creatinine measurement between laboratories. Although standardization provides more consistent serum creatinine values, the values are slightly lower, on average, than those before creatinine standardization.10,21 Most drugs’ labeling were developed prior to standardized calibration of creatinine assays. This has made assessing kidney function for the purpose of drug dosing adjustment more complex. Thus, it is important to determine how pharmacists in Minnesota are assessing kidney function for the purpose of drug dosage adjustment. Methods:

A cross-sectional survey was distributed to pharmacist members of the Minnesota Pharmacists Association (MPhA) and the Minnesota Society of Health System Pharmacists (MSHP). The 13-item questionnaire was created and administered through a Web-based survey program, SurveyMonkey. The University of Minnesota institutional review board approved the survey and overall research plan. Members of MPhA were reached through the January CAPS newsletter. MSHP’s members were invited to participate through an email sent in December 2010. The questionnaire addressed the following: equation(s) used to estimate kidney function for drug dosage adjustment, body weight choice for the C-G equation, adjustment of serum creatinine values based on age, and knowledge of eGFR reporting and serum creatinine standardization. Demographic information on responding pharmacists was also collected. Results:

The survey was sent to a total of 1110 pharmacists, 367 pharmacists in MSHP and 743 pharmacists in MPhA. 164 pharmacists completed the survey for a response rate of 15%; however the number of dual members is not known, thus the response rate may be higher. Most of the pharmacists who responded to the survey worked in the hospital setting and about half of all respondents were under age 40. In addition, 68% had a PharmD degree and 41% had residency training. Most pharmacists used the C-G equation (99%) while only 14% reported using Jelliffe, 13% MDRD, 10% Salazar-Corcoran, and 6% Modified-Jelliffe at some time in their practice setting (Figure 1). Pharmacists reported using a variety of weight parameters and Kidney Function continued on page 11

Kidney Function continued from page 10 adjusting the serum creatinine value in the C-G equation given various patient scenarios. A summary of the various methods can be found in Figures 2-3. In obese patients, 86% reported using adjusted body weight and 64% reported using ideal body weight, either all or some of the time. In non-obese patients, 80% reported using actual body weight and 82% reported using ideal body weight, either all or some of the time. Values of serum creatinine less than 1 mg/dL were reported to be adjusted to 1 mg/dL (or another value) by 62% of pharmacists. Of the pharmacists who adjust serum creatinine values when the reported value is less than 1 mg/dL, 53% reported making this adjustment at a certain age cutoff. A variety of age cutoffs were reported with age 65 appearing most frequently. 58% of pharmacists were unsure if their institution was utilizing a standardized serum creatinine assay. 86% of pharmacists were aware of their institution’s reporting of automated eGFRs; 75% of pharmacists indicated their institution did report and 11% indicated their institution did not report eGFR values. Discussion:

Providing optimal medication therapy is often dependent upon estimating a patient’s kidney function. Overestimating kidney function may result in drug toxicity, while underestimating kidney function may lead to subtherapeutic dosing and treatment failure. Several equations exist to determine drug dosing in patients with impaired kidney function; however, none of the equations are perfect. The C-G equation was developed in 1976 to estimate CrCl and is used as a rough estimate of GFR.2 The majority of kidney drug dosage adjustments have been determined using CrCl and the C-G equation as the standard. The MDRD 4-variable equation was originally developed in 1999. It has been shown to be more accurate than the C-G in estimating GFR.8,11 However, it is not very accurate in individuals with a GFR > 60 mL/min/1.73m2. The MDRD 4-variable equation was re-expressed for use with standardized serum creatinine values. The newer CKD-EPI equation was developed for use with standardized serum creatinine and is more accurate than the MDRD equation in patients with GFR>60 mL/min/1.73m2. The C-G equation cannot be re-expressed for standardized creatinine because the creatinine method used in the development of the equation is no longer in use and samples from the study are no longer available.12 All of these equations are limited by the use of creatinine as a filtration marker. The serum level of creatinine is determined by factors other than the GFR, such as kidney tubular secretion, diet, and muscle mass. The MDRD and CKD-EPI equations more accurately estimate GFR than C-G and are used to stage chronic kidney disease.11 However, as noted previously, most dosing recommendations were not based on measured or estimated GFR but rather estimated CrCl.5 Based on our survey results, C-G was the equation predominantly used by Minnesota pharmacists for drug dosage adjustment in patients with kidney dysfunction. Use of the C-G equation is consistent with the FDA’s current recommendation for pharmaceutical companies.5 However, the FDA has recently issued an updated draft guidance document for kidney impairment that recommends use of both MDRD for eGFR and C-G for eCrCl.

Final recommendations have not been published.6 The Nephrology Practice and Research Network of the American College of Clinical Pharmacy (ACCP) also recommends estimating kidney function using both the C-G equation and an appropriate GFR estimating equation. The re-expressed MDRD or CKD EPI equation should be utilized if the laboratory uses a calibrated serum creatinine assay. If suggested drug dosage adjustments differ based on results from each equation, the clinician should consider the clinical scenario, evaluate the risk-benefit ratio of potential under- versus overdosing, and use clinical judgment to determine whether the higher or lower dose may be more appropriate as the initial dose in that individual patient.13 There was significant variability in the choice of weight used in the C-G equation (i.e. ideal versus actual or adjusted body weight). Based on our survey, Minnesota pharmacists are consistent in that few pharmacists use actual body weight for obese patients. Results were much more variable between the use of adjusted body weight and ideal body weight in obese patients. Similarly, for non-obese patients, only 2% reported always using adjusted body weight but many pharmacists used actual or ideal body weight. Use of various weight parameters in the C-G equation increases the variability in results from one practice to another. A recent article by Pai reviews the most appropriate weight parameters to use in obese patients when using C-G or eGFR equations, such as MDRD or CKD-EPI. Evidence supports use of total body weight (aka actual body weight) in the C-G equation unless the patient is obese (BMI >30). In obese patients, lean body weight (LBW2005-Figure 4) is a better weight parameter to use than ideal body weight. For eGFR equations, multiply the eGFR by the patient’s BSA, using the Mosteller BSA method (Figure 4).14 Of note, using the Mostellar BSA adjustment method can greatly overestimate eGFR in morbidly obese patients. The ACCP Nephrology Practice and Research Network also supports use of lean body weight in the C-G equation for obese patients.13 Unfortunately, our survey did not specifically query about the use of lean body weight in the C-G equation in obese patients. In 2005, the NKDEP initiated a creatinine standardization program to reduce interlaboratory variation in creatinine assay calibration.11,19 Prior to creatinine standardization, variation in creatinine assays resulted in inconsistent creatinine values and thus potentially inconsistent drug dosing recommendations. Most clinical laboratories are now utilizing creatinine assays that have calibration traceable to an isotope dilution mass spectrometry (IDMS) reference. Assay calibration yields more consistent but slightly lower serum creatinine values, on average, than the values yielded prior to implementation of standardized creatinine.21 Lower serum creatinine values result in a higher eCrCl calculation that may result in a higher recommended dose as compared to the timeframe before creatinine standardization. A majority of Minnesota pharmacists, approximately 58%, were unaware of whether or not serum creatinine values from their clinical laboratory were standardized. More education is needed, as pharmacists should understand the implications of using standardized creatinine values.

Kidney Function continued on page 12 Minnesota Pharmacist Winter 2012 n

Kidney Function continued from page 11 Conclusions:

Appropriately assessing kidney function is imperative to properly dose drugs eliminated by the kidneys. The C-G equation is predominantly used by Minnesota pharmacists to estimate kidney function for drug dosing purposes. But creatinine assay standardization presents additional challenges when interpreting C-G results. Pharmacists need to understand the implications of standardized creatinine values and weight parameters on the variability of CrCl results when using C-G for drug dosing in patients with reduced kidney function, especially with narrow therapeutic index drugs and in critically ill patients. A standardized approach to drug dosage adjustment in patients with stable kidney function, as suggested by the ACCP Nephrology Practice Research Network, will help reduce variability in drug dosing adjustments from one practice to another.

Figure 4: Weight Parameter Adjustments for use in Estimating CrCl and GFR for Drug Dosage Adjustment in Obese Patients

References: 1 Bouchard J, Macedo E, Soroko S, et al. Comparisons of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury. Nephrol Dial Transplant. 2010; 25:102-107. 2 Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16:31-41. 3 Demirovic JA, Pai AB, Pai MP. Estimation of creatinine clearance in morbidly obese patients. Am J Health-Syst Pharm. 2009; 66:642-648. 4 Dowling T, Matzke G, Murphy J, Burckart G. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches. Pharmacotherapy. 2010; 30(8):776-786. 5 Food and Drug Administration. Guidance for Industry: Pharmacokinetics in Patients with Impaired Renal Function â&#x20AC;&#x201D; Study Design, Data Analysis, and Impact on Dosing and Labeling. Department of Health and Human Services; May 1998. http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm064982.htm. 6 Food and Drug Administration. Guidance for Industry: Pharmacokinetics in Patients with Impaired Renal Function â&#x20AC;&#x201D; Study Design, Data Analysis, and Impact on Dosing and Labeling (Draft Guidance). Department of Health and Human Services; March 2010. http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm064982.htm. 7 Hermsen ED, Maiefski M, Florescu MC, et al. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations for Dosing Antimicrobials. Pharmacotherapy. 2009; 29(6):649-655. 8 Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999; 130:461-70. 9 Moranville M, Jennings H. Implications of using modification of diet in renal disease versus Cockcroft-Gault equations for renal dosing adjustments. Am J Health-Syst Pharm. 2009; 66(2):154-161. 10 Myers G, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem. 2006; 52(1):5-18.

Kidney Function continued on page 15 12

Minnesota Pharmacist Winter 2012 n

4 Fraud and Abu se Training 4 Pseudoephed rine Log 4 OSHA Requ irements 4 HIPAA Priva

Policies an cy and Security d Procedur es Quality As Program surance (QA)

Is a QA Program Missing From Your Checklist? Pharmacy Quality Commitment™ (PQC™) is what you need! Reduction of medication errors and implementation of a QA program are no longer options. A growing number of pharmacy network contracts require a process in place and no matter what it is called, QA, CQI, safe medication practices, or medication error identification and reduction program – PQC™ is the answer.

• • • • • •

The PQC™ Program: Legally protects reported data through a federally listed Patient Safety Organization (PSO) Helps increase efficiency and improve patient safety through a continuous quality improvement (CQI) process Provides easy-to-use tools to collect and analyze medication near miss and error data Presents a turnkey program to help you meet obligations for QA and CQI requirements Includes simple method to verify compliance Offers excellent training, customer service and ongoing support

Not all programs are the same, make sure your pharmacy and your data is protected. Pharmacies that license PQC™ and report patient safety events are provided federal legal protection to information that is reported through the Alliance for Patient Medication Safety (APMS) – a federally listed PSO. To learn more about PSOs, visit www.pso.ahrq-gov/psos/fastfacts.htm.

Call toll free (866) 365-7472 or go to www.pqc.net for more information. PQC is brought to you by your state pharmacy association. Minnesota Pharmacist Winter 2012 n

feature

MN PhARMACY

Minnesota Practice-Based Research Network: An Update By Rita Tonkinson

Minnesota’s pharmacy practice-based research network (PBRN) was introduced about five years ago to pharmacists in the November/December 2007 issue of the Minnesota Pharmacist. It was formally launched in February 2008. Since the initial article, little has been reported in this publication. It’s time to focus attention on the progress of the network, and encourage Minnesota’s pharmacists to review the programs, take a look at the opportunities, and consider the options.

PRACTICE BASED RESEARCH NETWORK

The PBRN was announced by Jon Schommer, PhD, RPh, professor, University of Minnesota College of Pharmacy, in the above mentioned article. A few Minnesota Pharmacist readers may not recall the article; others may have lost track of the network’s progress. Following is a brief history, followed by an update. Much of this recap is taken from Schommer’s 2007 article and from the white paper written in May 2010 with Schommer as the lead author. The white paper was also supported by a distinguished advisory/review board of pharmacists, national association leaders and academic pharmacy leaders. The paper “Establishing Pharmacists Practice-Based Research Network, an American Pharmacists Association (APhA) Foundation White Paper,” describes the process of looking at more than “two decades of success for PBRNs in primary care practice and the coincident evolution of community pharmacy practice as a recognized patient access point.” In the paper, Schommer cites the point that medications are used by almost all members of society and pharmacists are accessible providers of medications to the public. The paper clearly defines the process leading up to the launch in Minnesota. In the Executive Summary, Schommer described what he called a “Research Gap Analysis.” He said that “leaders within the APhA Community Pharmacy Residency Program (CPRP) began discussions regarding the creation of a Practice-Based Research Network using CPRP sites (named PBRNet). To begin dialogue for this idea, 15 individuals who were affiliated with community pharmacy residency programs convened to participate in a focus group on April 5, 2009 in San Antonio, Texas. The purpose of this inquiry was to understand the most important elements needed for an infrastructure to support a PBRNet.” To understand the scope of a PBRN, the nationally accepted definition of a practice-based research network is helpful. Schommer describes a PBRN as “a group of ambulatory practices devoted principally to the primary care of patients, affiliated with each other (and often with an academic or professional organization) in order 14

Minnesota Pharmacist Winter 2012 n

to investigate questions related to community based practice.” During the last few months of 2007, the Minnesota Pharmacists Association (MPhA) and the University of Minnesota College of Pharmacy developed a Minnesota Pharmacy PBRN, introducing the concept at MPhA’s Pharmacy Nights that fall. At that time, 30 pharmacies were enrolled. In order to be considered a PBRN by national funding agencies, at least 15 practice sites are required. Beginning in March of 2009, grant proposals were submitted for funding. Requirements for consideration by a funding agency included in the grant competitions are: 1) a “network capacity” consisting of pharmacies willing and able to collaborate on projects and 2) an infrastructure for managing the projects. The two organizations have developed a PBRN “Capacity Portfolio,” a document for internal use and to be submitted to funding agencies as part of Minnesota PBRN proposals. This is a dynamic document, expanding to reflect the developing PBRN network. The building blocks of a PBRN included a sponsoring organization, community pharmacy residency program accreditation requirements in place and the development of technology standards. In his paper, Schommer described results of a survey of the Community Pharmacy Residency Program members (November 2009) that revealed some barriers to securing finding for conducting practice-based research. These perceived barriers included access to electronic medical records and lack of resources/time, and experience of securing funding. The next step was developing an infrastructure: 1) director, 2) coordinator, 3) one-way communication, 4) two-way communication, 5) membership roster, 6) meetings, 7) board, and 8) human subjects’ protection management. Schommer also described other infrastructure elements that might be necessary, such as 1) research assistants, 2) information technology, 3) regulatory compliance, or 4) research consulting expertise. To this end, PBRNs can use an academic institution’s resources already in place as partners, where research, grant writing, data management, one- and two-way communications and other expertise are available. The ultimate goal, of course, is to translate the research findings into practice, i.e. enhance patient care and underscore the importance of accessibility to pharmacists’ care. The Minnesota Pharmacists Association reported that as of December 2009, 305 pharmacy practice locations were part of the Minnesota PBRN. Among those practice sites were: 1) communitybased pharmacies, 2) hospital-based pharmacies, 3) communitybased clinics, and 4) one investigational drug service (not available to the general public). All but six of the PBRN pharmacies dispense PBRN Update continued on page 15

PBRN Update continued from page 14 medication to the public. An array of PBRN research collaborations can include, but are not limited to, patient screening, education, referral, continuity of care, and follow-up as well as drug regimen review, patient outcomes and data retrieval. In its ongoing role as a valuable resource for its members and for the public, MPhA has further enhanced its role in disseminating PBRN network information on its Web site and through other communications with its members. Julie K. Johnson, PharmD, executive vice president and CEO, MPhA, served in an advisory capacity in the beginning of the PBRN program and continues to serve in various ways as the network continues to develop. If you wish to view the current list of PBRN projects and locate the map of PBRN locations, visit: http://www.mpha.org/associations/9746/files/PBRN/index.html. “Dr. Schommer has called participating in such a network as collecting information in real-world settings to help address societal, community, or professional questions that relate to medication use,” said Johnson. “Based on feedback from individual pharmacists involved in the PBRN, while continuing to provide expanded patient services and promote the value of pharmacists in the health care community, many have said they have enhanced their professional and personal experience.” During 2011, Schommer said in a communication on the status of PBRN, there were ongoing preparations for funding project proposals. There is also a listing of papers covering current practice-based research on the College of Pharmacy Web site, Innovations in Pharmacy. Visit this site for additional important information: http://www.pharmacy.umn.edu/innovations/pbresearch/home html In the same communication Schommer described goals for 2012: “Our goals for 2012 are to continue preparing project proposals and to complete funded projects. We are nearing the point in our development as a PBRN where we can discuss the types of projects for which we have achieved the greatest success and consider ways to invest in those areas. Our PBRN is beginning to establish an identity, and we can consider ways to build upon that foundation. One challenge is to anticipate how our capabilities and capacities can fit into the opportunities that are still emerging.”

Kidney Function continued from page 12 11 National Kidney Disease Education Program. Laboratory Professionals: Creatinine Standardization and Estimating & Reporting GFR. Available online at: http://www.nkdep.nih.gov.floyd.lib.umn.edu/labprofessionals/ index.htm. 12 National Kidney Disease Education Program. Chronic Kidney Disease and Drug Dosing: Information for Providers (Revised January 2010). Available online at: http://www.nkdep.nih.gov/professionals/drug-dosing-information.htm. 13 Nyman HA, Dowling TC, et al. Use of the Cockcroft-Gault versus MDRD Study Equation to Dose Medications: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2011. 14 Pai MP. Estimating the glomerular filtration rate in obese adult patients for drug dosing. Advances in Chronic Kidney Disease. 2010; 17(5): e53-e62. 15 Prigent A. Monitoring renal function and limitations of renal function tests. Semin Nucl Med. 2008; 38(1):32-46. 16 Salazar DE, Corcoran GB. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med. 1988; 84:1053-60. 17 Siew E, Matheny M, Ikizler TA, et al. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int. 2010; 77(6):536-42. 18 Stevens L, Nolin T, Richardson M, et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis. 2009; 54(1):33-42. 19 Stevens L, Stoycheff N. Standardization of serum creatinine and estimated GFR in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2008; 51(4):S77-S82. 20 Verbeeck RK, Musuamba FT. Pharmacokinetic and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol. 2009; 65:757-773. 21 Wade W, Spruill W. New serum creatinine assay standardization: implications for drug dosing. Ann Pharmacother. 2007; 41(3):475-480.

As of February 2012, the Minnesota PBRN consisted of 366 geographically dispersed pharmacies and 23 principal investigators from the University of Minnesota (See Appendix D of Dr. Schommer’s most recent summary on MPhA’s Web site). A summary of projects that have utilized the Minnesota Pharmacy PBRN can be found in Appendix E of the same document entitled, “The Minnesota Pharmacy Practice-Based Research Network.” Review the complete text of the white paper, “Establishing Pharmacists Practice-Based Research Network, an American Pharmacist Association Foundation White Paper,” by following the link: http://www.pharmacist.com/AM/Template. cfm?Section=Professional_Advancement&Template=/CM/ ContentDispaly.cfm&ContenID=23805 Rita Tonkinson is a contracted staff writer for the association, who provides insightful looks into the field of pharmacy for our readers.

Minnesota Pharmacist Winter 2012 n

PHARMACY MARKETING GROUP, INC. • PHARMACY and the law

recordkeeping isn’t that important, is it? by Don McGuire, RPh, JD

This series, Pharmacy and the Law, is presented by Pharmacists Mutual Insurance Company and your State Pharmacy Association through Pharmacy Marketing Group, Inc., a company dedicated to providing quality products and services to the pharmacy community. Terry at Midtown Pharmacy was dealing with another recurring frustration. The pharmacy’s usual generic brand of atenolol was backordered again. Terry ordered a couple of 100 count bottles to hold them over until the usual brand was available again. Terry didn’t bother to update the computer database to reflect this change because she would then just have to change it back again two days from now. The change isn’t really that important anyway, right? Wrong. Your documentation is the only thing you will have later to prove what you did today. We all forget things, especially when they come up weeks or months later. Consider the following claim scenario. A pharmacy was sued by a former patient over some faulty transdermal fentanyl patches. The patient alleged that he was injured due to the patch releasing the medication too quickly. The patient’s profile indicated that he received the patch manufactured by company A. Company A’s product had, in fact, been recalled due to this very problem. The patient was sure that the excessive dose delivered had caused him to be hospitalized. The pharmacy staff went through months of anxiety and expense while producing records and being deposed. What everyone learned at the end was that the patch received by the patient wasn’t manufactured by company A. He had received patches manufactured by company B. This was discovered when reviewing the invoices from the time period in question. Company B’s product had been purchased because of the recall of company A’s patches. However, the patient profile indicated that the patient had received Company A’s patches. Proper recordkeeping would most likely have prevented this pharmacy from suffering through months of litigation. A second consideration here is billing. In today’s world, it is more important than ever to bill for what was actually dispensed. Third-party payers expect and demand that their customers receive the product that is billed to the third-party payer. While the two different fentanyl patches discussed above may be clinically interchangeable, they are probably not the same when it 16

Minnesota Pharmacist Winter 2012 n

comes to acquisition cost or reimbursement In litigation, documentation rates. One may have been non-formulary, is everything. If it wasn’t for example. This difference is multiplied if documented, it wasn’t one product is the brand name one. Clinically, done. Many cases have none of the differences are significant. However, turned on seemingly small we aren’t talking about therapeutics. We are documentation issues. talking finances and recordkeeping. This sort of discrepancy can lead to repayment demands, even penalties and interest, following an audit. The importance of recordkeeping shouldn’t be overlooked. In litigation, documentation is everything. If it wasn’t documented, it wasn’t done. Many cases have turned on seemingly small documentation issues. Perpetual inventory totals, timecards, delivery records, pick-up logs, documentation of counseling (or refusal of counseling) are some other examples of records that have become key points in a case. The lesson here is that no record is too small or too trivial to be skipped over. Update those inventory changes as they come in. It may seem burdensome at the time, but there are potential benefits later.

© Don R. McGuire Jr., RPh, JD, is General Counsel at Pharmacists Mutual Insurance Company. This article discusses general principles of law and risk management. It is not intended as legal advice. Pharmacists should consult their own attorneys and insurance companies for specific advice. Pharmacists should be familiar with policies and procedures of their employers and insurance companies, and act accordingly.

A Buying group for independent retAil phArmAcies

...owned by 19 state pharmacy organizations ...a leader negotiating on behalf of independents ...saving pharmacies money for more than 25 years ...financially supports the state pharmacy organizations ...serving pharmacies nationwide 1-888-200-0998 | www.pacealliance.com

Minnesota Pharmacist Winter 2012 n

Student Perspective

Home care: A new frontier for pharmacy practice Delford Ilara Doherty, PharmD and MPH Candidate, 2010; University of Minnesota College of Pharmacy and School of Public Health

With millions of baby boomers retiring and turning to Medicare for their health insurance needs, many in the health care industry are looking to combat rising health care costs in order to sustain this program. Pharmacists are well-trained and well-positioned to play an integral role in Medicare cost containment. The model for pharmacist involvement in health care already exists in current programs such as medication therapy management (MTM). The most promising frontier for pharmacists in the rapidly changing health care landscape is home health care-based MTM. A valuable opportunity

For some time, pharmacists have ceded home health care to public health nurses who provide services to patients in their homes. My first experience with home care MTM came on my ambulatory care rotation with Shannon Reidt, PharmD, MPH, BCPS, at the Minnesota Visiting Nurse Agency in Minneapolis. Before this rotation, I had a vague perspective of home care as the territory of nurses and public health practitioners. It soon became clear to me, however, that home care-based MTM is a public health necessity and one that presents a great opportunity for pharmacists. The population of homebound seniors is growing as older patients attempt to avoid the cost of nursing home institutionalization. Homebound patients are missed opportunities for clinical interaction. They often have complex medical histories, take multiple medications, have multiple prescribers, use multiple pharmacies, have mobility problems, and lack easy access to pharmacies and clinics that provide MTM services. These patients would greatly benefit from MTM services, especially when delivered in conjunction with a home care agency team. Home care has largely been provided by family care providers, home care nurses, and other professionals who are not primarily trained to identify, rectify, and prevent drug therapy problems. This is a disservice to home care patients with many ramifications, including the burden of illness, quality-of-life issues, and substantial cost to both patients and taxpayers. Pharmacy has the opportunity to correct this problem. The pharmacy workforce is expanding rapidly and ingenuity, especially on the part of recent graduates, will soon be a deciding factor in pharmacists’ careers. It is imperative for new practitioners to consider opportunities in home health care.

when prescribers lack knowledge of the patient’s complete medication regimen or don’t understand how medications are used in the home. Home health care providers also often deal with low reimbursement rates. New practitioners facing record student loan repayments may find this a serious obstacle. However, it’s too soon to dismiss home health care-based MTM. The passage of health care reform and emphasis on preventative care are likely to open up exciting possibilities for pharmacy practice. I believe home care will emerge as a leading practice in providing preventative care to America’s aging population. This is an opportune time for new practitioners to use ingenuity to position themselves for this emerging practice in settings such as home infusion clinics, long-term care facilities, MTM clinics, and others. Pharmacists should also consider developing models and mechanisms to partner with home care providers, managed care organizations, insurance agencies, and private and public health systems. Determining patient needs

There is a pressing need for pharmacists to practice home carebased MTM. Being in a patient’s home offers the home care pharmacist the opportunity to evaluate the entirety of the patient’s circumstances, allowing for a holistic assessment of clinical needs while considering the physical, functional, and environmental factors affecting the patient’s health. Home care pharmacists also have access to all medications, herbal products, and OTC products the patient is using, as well as to caregivers who can offer their own perspective. This kind of in-depth evaluation could not be accomplished in the clinical setting and produces superior results, which may prove to be the most valuable aspect of home health care-based MTM services. Home health care is a new frontier for pharmacists that makes it possible for them to influence the lives of patients by preventing disease burdens and the costs associated with drug therapy problems. Current and future practitioners should consider the possibility of a career in home care-based MTM, which could take the form of patient care, consultation, policy, or regulation. Because of the changing health care delivery landscape, home care-based MTM is a moral and professional imperative.

Don’t let barriers obstruct patient care

The greatest impediment to home care practice is reimbursement. Current home health care practitioners often must spend extensive time coordinating patient care with multiple providers, especially 18

Minnesota Pharmacist Winter 2012 n

Del Doherty is a fourth-year PharmD & MPH candidate at the University of Minnesota College of Pharmacy.

MPhA Staff Amanda Ewald, Vice President, Finance and Accounting. Amanda oversees all of MPhA’s financial activities including development of monthly financial statement, paying bills, etc. Email: amandae@ewald.com

David Ewald, President. David helps Julie Johnson’s endeavors as appropriate to help maintain a strong relationship between staff and the organization, and to provide assistance in seeing that MPhA continues to make progress toward its mission. Email: davide@ewald.com

Jacquie Jaskowiak, Assistant Account Executive. Jacquie assists Julie with some of the day-to-day operational activities, and takes a strong role in membership recruitment and retention efforts. Email: jacquiej@ewald.com

Bill Monn, Vice President, Member Services and Marketing. Bill’s responsibilities include supervising the member services department, contract management and assuring appropriate resource and service levels. Bill also works with staff members and at times directly with clients to develop strategic business plans that promote successful and profitable operations for client organizations. Email: billm@ewald.com

Chris Swanson, Member Service Director. Chris helps with events, membership and other projects. She is one of the friendly people who answer questions when people call the MPhA office. Email: chriss@ewald.com Anna Wrisky, Communication Specialist. Anna is responsible for producing MPhA’s communications including CAPS, e-News and the Minnesota Pharmacist journal and manages the MPhA Web site. Email: annaw@ewald.com

Stay

Connected

Find us on Facebook and LinkedIn. Minnesota Pharmacists Association

Kathie Pugaczewski, Vice President, Communication and Technology. Kathie is responsible for supervising the management of communication, Web sites, webinars, developing social media strategy and managing technology operations. Email: kathiep@ewald.com Kelly Sprague, Meeting Planner. Kelly is responsible for assisting in the excellent execution of MPhA’s education programs. Email: kellys@ewald.com

Laurie Pumper, Communication Director. Laurie works with the MPhA Editorial Advisory Board to develop content for the association’s journal and other communication vehicles, and she assists in providing marketing support for advertising. Email: lauriep@ewald.com

Minnesota Pharmacist Winter 2012 n

MPha board of directors and volunteers The Minnesota Pharmacists Association is comprised of many important areas that affect the association as a whole. Some of these areas are elected positions (board of directors), and others are by appointment or volunteer (committees, task forces, etc.). All members of MPhA are eligible to run for an elected position or participate in other areas as representatives of their setting, academy or district. board of directors

The MPhA Board of Directors (BOD) is comprised of elected officers and representatives who represent all pharmacy practice settings and geographic regions in Minnesota. The Minnesota Pharmacy Student Alliance (MPSA), the University of Minnesota College of Pharmacy, and the Minnesota Society of Health-System Pharmacists (MSHP) also sit on the MPhA board as representatives of their respective pharmacy organizations. The board meets bi-monthly, and is responsible for reviewing and revising the MPhA strategic plan and incorporating resolutions passed by the MPhA House of Delegates. Elections for open board positions occur annually, with a swearing-in ceremony at the conclusion of each MPhA Annual Meeting. If you are interested in running for a board position, please contact Julie Johnson at the MPhA office. House of Delegates

The House of Delegates (HOD) reviews recommendations and policies to go before the Board of Directors, and is comprised of delegates from each of MPhAâ&#x20AC;&#x2122;s districts and academies for a full representation of pharmacy in Minnesota. The largest HOD meeting is held each June during the MPhA Annual Meeting. Any MPhA member may volunteer to be a district/academy delegate for the HOD. Individual district and academy chairs will determine the amount of delegate reimbursement. If you are interested in being a delegate, please contact your chair or Julie Johnson at the MPhA office. academies

MPhA recognizes the diverse areas of practice in Minnesota. Academies allow members in the same practice setting to interact and dis-

Minnesota Pharmacist Winter 2012 n

mpha 2011/2012

board of directors Executive/finance Committee

PRESIDENT: Scott Setzepfandt Genentech Business Phone: 952-469-5452 setzepfandt.scott@gene.com PAST PRESIDENT: Brent J. Thompson FirstLight Health System Business Phone: 320-225-3595 bthompson@fl.hs.org PRESIDENT-ELECT: Martin Erickson Gallipot, Inc. Business Phone: 651-389-0906 maerickson3rd@gmail.com SECRETARY-TREASURER: William Diers United Hospitals - Inpatient Business Phone: 651-241-8851 billdiers@comcast.net SPEAKER: Meghan Kelly kelly476@umn.edu EXECUTIVE VICE PRESIDENT: (Ex-Officio): Julie K. Johnson Minnesota Pharmacists Association Business Phone: 651-290-7486 julie@mpha.org RURAL BOARD MEMBERs

Eric Slindee (term ends in 2013) Wittâ&#x20AC;&#x2122;s Pharmacy Business Phone: 507-886-2322 slindee@harmonytel.net

Mark Trumm (term ends in 2012) Trumm Drug Business Phone: 320-763-3111 mtrumm@trummdrug.com METRO BOARD MEMBERs

Cheng Lo (term ends in 2013) Phalen Family Pharmacy Business Phone: 651-209-9000 chenglo11@gmail.com

James Marttila (term ends 2012) Mayo Clinic Business Phone: (507)284-8243 marttila.james@mayo.edu

BOARD MEMBERS AT LARGE

Tim Cernohous (term ends in 2013) University of Minnesota - Duluth Business Phone: 218-726-6005 cern0037@umn.edu Tiffany Elton (term ends in 2012) Min-No-Aya-Win Clinic Pharmacy Business Phone: 218-878-2154 tiffanyelton@fdlrez.com Amy Sapola (term ends in 2013) Mayo Clinic Sapola.Amy@mayo.edu Jill Strykowski (term ends in 2013) Allina Hospitals and Clinics Business Phone: 763-236-4137 jill.strykowski@allina.com Jason Varin (term ends in 2013) Cub Pharmacy - Chanhassen Business Phone: 952-934-2865 vari0001@umn.edu

student representation

Minneapolis MPSA Student Liaison: Kandace Schuft schuf007@umn.edu DULUTH MPSA Student Liaison: Jeremy LeBlanc lebla066@d.umn.edu Ex-Officio

Rod Carter, COP U of M College of Pharmacy Business Phone: 612-625-1135 carte068@umn.edu Julie K. Johnson, MPhA Minnesota Pharmacists Association Business Phone: 651-290-7486 julie@mpha.org Pharmacy technician rep.

Barb Stodola stodolab@aol.com

cuss issues important to their field. Each academy reports to the BOD for any action needing support, as well as the HOD. Current MPhA Academies include: • ACADEMIC • CHAIN MANAGEMENT • COMMUNITY • HOSPITAL • INDEPENDENT OWNER • INDUSTRY • LONG TERM CARE • MANAGED CARE

spring

pharmacy nights

• medication therapy management

Save the date!

• Technician

Each academy is appointed one delegate at HOD meetings, with one additional delegate per every additional 50 members in the academy.

April 5 • Twin Cities

Each academy chair is responsible for setting meetings and agendas for the academy’s members. New academy chairs are elected each odd year by the members of the academy.

April 19 • Rochester

Members may choose to participate in multiple academies for a nominal fee, but may only serve as a delegate for any one academy or district per HOD meeting. Contact Julie Johnson at the MPhA office for more information on academies. districts

April 12 • Duluth April 26 • Alexandria May 9 • Brainerd May 10 • Bemidji

committees and task forces

In order to address pharmacy issues on multiple levels, MPhA has designated committees and task forces to review and recommend action to the BOD. For more information on current committee and task force opportunities, see the volunteer form on the next page. • Public affairs and policy development • professional affairs • awards • community pharmacy business

Minnesota is divided into seven districts to allow members in each district to network and discuss regional news and practice ideas.

• educational advisory • Editorial Advisory Board

Each district reports to the BOD for any action needing support as well as the HOD. Each district has three delegates on the HOD, with one additional delegate for every additional 100 members in the district. Each district chair is responsible for setting meetings and agendas for their members. New chairs are elected each odd year by the members of the district. Some districts take advantage of local Pharmacy Night meetings to gather and discuss district business, including the election of officers.

Minnesota Pharmacist Winter 2012 n

mpha committees and task forces the power behind the association The Minnesota Pharmacists Association’s committees and task forces address pharmacy issues on every level. Members of all practice settings (including technicians and students) are needed to provide valuable insight and feedback on the workings and advancement of the association. To become active in a committee or task force, submit the interest form located below, or contact the MPhA office for more details. MPhA’s committees and task forces guide the association, making it as successful as it is today! Public Affairs & Policy development committee

Educational Advisory committee

Actively engage in grassroots efforts to pursue MPhA initiatives, monitor and react to state and federal legislation and policies. Review and recommend new business for the MPhA Board of Directors and House of Delegates. Meets 10x/Year.

Review and suggest educational opportunities for members that will allow them to grow and stay current with changes in the field. Meets 3x/Year. Committee members will participate in one of the three planning subgroups as a non-committee member: Annual Meeting, Fall Clinical Symposium, Midwinter, Technican Summit, or Technician Conference.

professional affairs committee

Define and review the pharmacist’s role in the medical home. Review health care reforms, pharmacy practice act, dispensing compensation, and pharmacy services. Address issues related to the pharmacist’s scope of practice and the advancement of pharmacy. Meets 10x/Year. Awards committee

Editorial Advisory Board

Suggest ideas for articles and/or authors. If willing, advisory board members might write articles for the journal. Meetings are held at the MPhA office. Meetings typically last two hours or less. Members may use the conference call option. Meets 4x/Year.

Review and recommend changes to the MPhA award system. This includes changes in criteria or the creation of new awards. Review nomination forms and select award recipients. Meets 2x/Year. Community Pharmacy Business committee

Identify and pursue initiatives to improve the community pharmacy business climate. Support pharmacy business education in economic strategies. Develop materials to help pharmacists with provider issues. Meets 10x/Year.

Committee/task force volunteer application The Minnesota Pharmacists Association relies on its members and pharmacy professionals to lend their time and insight to our committees and task forces to make them successful components of our profession. The association is continually seeking pharmacists, students, technicians and other pharmacy professionals to become involved and be active in promoting and supporting the work of the association and making pharmacy in Minnesota a profession worth fighting for.

Support the role of pharmacists in the field and the association. YOU can make a difference!

We welcome your interest in serving on one of the above committees or task forces. Please submit this form by fax or mail to the MPhA office. Sign up today and join your peers to take an active role in the perception of pharmacy in Minnesota! YES! I would like to serve on the following committee/task force: ________________________________________________________________________________ Name: ______________________________________________Organization:_________________________ Address: _______________________________________________ City: _______________ Zip: _________ Phone: _______________________ Fax: __________________ Email: ______________________________

Minnesota Pharmacist Winter 2012 n

association benefits The Minnesota Pharmacists Association’s number one priority is its members. MPhA strives to provide services and benefits to our members that not only promote the profession of pharmacy in Minnesota, but the professional lives of our members as well. Ranging from advocacy and communication to discounted professional and business programs, we are always on the search for benefits that are valuable to you as pharmacy professionals.

Products and Services

Many of our benefits can be accessed easily through our Web site. From online dues renewal, conference registration and member searches, we strive to not only make membership valuable, but easy to use and navigate. Not able to find what you are looking for? Contact our office and we can help point you in the right direction.

Business Services • Coupon Redemption Program • PAAS 3rd-Party Audit Services • Credit Card Processing Services • Pharmacists Financial Service • Discounted AAA Automotive Membership

To access your online member benefits, use your email and personal password to login. Your MPhA Member Portal page will allow you quick access to view your current contact information, registered events, and invoice statements. If you forget your password, use the password link to have it reset through your email account. Still having problems? Give us a call to confirm we have the correct email on file. Membership Dues:

Check with your employer to see if they cover a portion of MPhA membership. Membership dues can be renewed online and a portion of your dues is tax deductible (consult your tax adviser with questions). We offer a variety of options to make payment more convenient, including a monthly debit program that will debit your credit card, checking or savings account each month (call the MPhA office to set up this feature). advocacy

MPhA works to provide members with a “voice” in pharmacy at the state and national levels. The association puts a “face on pharmacy” through media and outreach to health care entities who rely on MPhA for information and resources related to pharmacy services. Through legislative representation, policy planning, and lobbying, the association ensures that issues pertaining to pharmacy are not overlooked or undercut. We fight for the rights of pharmacists and pharmacy professionals to provide the highest level of care to the patients they serve. MPhA encourages members to become involved in this process by being active in grassroots actions and events. As a member, you will have access to important updates and resources made possible by your support. Professional development and education

MPhA provides a variety of events throughout the year to keep members involved in pharmacy issues while offering continuing education, networking opportunities and fun! Events are listed on the MPhA Web site and are open to all. Members receive a discount on selected event programming, such as Annual Meeting, Fall Clinical Symposium, and Midwinter Conference.

Members benefit from discounted rates and prices on both professional and business related services. Professional Services • Pharmacists Letter • Pharmacists Mutual Insurance • Technician Manuals

Communication

Communication is our cornerstone of keeping you informed of association, state and national news and action. Minnesota Pharmacist The Minnesota Pharmacist is the association’s quarterly journal that contains articles and features on today’s pharmacy topics, and mails to all MPhA members. CAPS CAPS is our monthly faxed/emailed newsletter that keeps pharmacy professionals abreast of timely pharmacy issues and happenings. The newsletter is faxed to all pharmacies in the state, and is emailed to all MPhA members. E-News E-News is our email newsletter that goes out to all subscribed members. Monthly e-news shares upcoming events and topics, while single e-news items may alert you to important legislative or MPhA issues. Pharmacy News Flash

Twice a week, Pharmacy News Flash is delivered by email to members. These updates include news about national issues affecting pharmacists, along with local headlines and job openings. Career center

Tailored to both our job seekers and employers, our Career Center allows you to browse openings or post opportunities at your convenience. Search for Minnesota locations, or broaden your search to outside states. The center holds a variety of options to tailor results to your needs. resources

Members receive special online access to pharmacy resources. From MTM templates and brochures to information on immunizations, we save you valuable time by having these resources readily available to you for use in your practice.

Online pharmacy education is also available through the MPhA Web site. Home Studies and Learn Something offer a variety of topics and timelines to fit your needs. Minnesota Pharmacist Winter 2012 n

mpha community pharmacy defense fund community pharmacy defense fund The Community Pharmacy Defense Fund was established by independent pharmacy owners and chain managers to develop a pool of funding that could be used to fund initiatives to move pharmacy from a position of defending the status quo to pursuing an aggressive agenda, thus combating the growing number of threats to community pharmacy, chief among them being:

I agree to contribute $1,000 per store. $1,000 x _________ stores = $____________________ I wish to contribute an additional $ ____________________ to help fund MPhA’s efforts to maintain a favorable climate for community pharmacy.

• The inability to negotiate with third-party payers. • Predatory pricing strategies and below-cost sales.

Name: ___________________________________________________

• The growing threat of mandatory mail-order plans and discriminatory co-pay incentives.

Organization: ______________________________________________

• The threat of continuing cuts in pharmacy reimbursement in the public and private sectors.

City: _________________________ State: ______ Zip: ___________

• The unrelenting drive by state officials to push the limits of personal importation of prescription drugs. • The probable increasing difficulty for rural pharmacies to remain viable and to transition ownership. Contributions of $1,000 per pharmacy are dedicated to the Community Pharmacy Defense Fund, and held in trust by the Minnesota Pharmacists Association. The fund is set up so that funding is directly applied to expenses associated with specific community pharmacy initiatives.

Address: __________________________________________________ Phone: ___________________________________________________ Fax: _____________________________________________________ Payment by: Check Mastercard

Visa

Discover

If paying by credit card, all of the following fields are required.

Card #: __________________________________ Expiration: _______ Signature: ________________________________ Sec. Code: _______ Billing Address:

Same as above

Address: __________________________________________________ City: _________________________ State: ______ Zip: ___________

Thank you to our defense fund supporters! Those listed below contributed to the 2011 Community Pharmacy Defense Fund.

Astrup Drug Baron’s Pharmacy Breen’s Pharmacy CVS Dakota Drug Erickson Drug Genoa Healthcare Goodrich Pharmacy HealthPartners

Minnesota Pharmacist Winter 2012 n

Hennepin County Medical Center Iverson Corner Drug Kemper Drug Lakes Area Pharmacy Lewis Family Drug-Luverne New Richland Drug Park Nicollet Health Services Phalen Family Pharmacy Planned Parenthood

Scofield Drug & Gift St Paul Corner Drug Thrifty White Pharmacy Trumm Drug Walgreens Warroad Heritage West Seventh Pharmacy

mpha pharmacy future fund pharmacy future fund The Minnesota Pharmacists Association established the Pharmacy Future Fund more than ten years ago to raise funds that would allow MPhA to move our efforts to support community pharmacy in Minnesota to a new level. This fund has provided the vehicle for MPhA to maintain full-time advocacy, to take on third-party issues, and to address the business needs of community pharmacists. While this program has enabled MPhA to pursue many objectives on behalf of community pharmacy, there are more that have been identified as priorities that we fully intend to pursue. Our motivation to accomplish these tasks is high, and eventually we will get there â&#x20AC;&#x201C; but resources behind motivation would enable a more rapid path to success.

I authorize my wholesaler(s) to place a one-tenth of a percent (0.1%) Pharmacy Future Fund contribution on my regular pharmaceutical purchase invoices. I understand that this is a donation to the MPhA Pharmacy Future Fund. Name: ____________________________________________________ Pharmacy: _________________________________________________ Address: __________________________________________________ City: _________________________ State: ______ Zip: ___________ Phone: ___________________________________________________ Fax: ______________________________________________________ Signature: __________________________________ Date: _________

Thank you to our future fund supporters!

The following contributed to the 2011 Pharmacy Future Fund. Bergh Pharmacy Bergs Pharmacy City Drug Corner Drug, LeSueur Crosstown Drug Eagle Drug Family Pharmacy South Family Rexall Drug Foley Drug

Globe Drug Goodrich Pharmacy Goltz Pharmacy Guidepoint Pharmacies Herrmann Drug Lakes Area Pharmacy Lake Country Drug Moob Pharmacy Parkers Trumm Drug

Pelican Drug Peterson Thrifty White Prescription Center Pro Pharmacy #1 Pro Pharmacy #2 Ramsey Pharmacy Range Drug St. Paul Corner Drug Scofield Drug

Throndset Pharmacy Trumm Drug #1 Trumm Drug Clinic Pharmacy Trumm Drug-Elbow Lake Trumm Drug-Glenwood Village Pharmacy & Gift

please support mpha to address the needs of community pharmacy!

Choose to support the Defense Fund or the Future Fund (or both!) by returning the information located under each fund to the MPhA office. If you have additional questions about our pharmacy funds, please call us during normal business hours (8:00 am to 5:00 pm) or send an email to info@mpha.org. Mail or fax form(s) to: Minnesota Pharmacists Association 1000 Westgate Drive, Suite 252 | St. Paul, Minnesota 55114 651.290.2266 fax Questions? 800-451-8349 or 651-697-1771

Minnesota Pharmacist Winter 2012 n

MPha award nomination form Please provide a letter of support for each award nominee describing in detail the reasons for the MPhA Awards Committee to consider your nominee. Include specific examples and/or details. Attach your nomination letter and any supporting documents to this form, including a current CV of nominee if possible. Nominations that do not include adequate information will not be considered until missing information is submitted. Nominators will be notified when nominations are received by the MPhA office and if additional information is required. Please see the MPhA Web site for additional award information and forms: www.mpha.org.

Harold R. Popp Award

Sponsored by MPhA, the Popp Award recognizes one pharmacist annually for outstanding services to the profession of pharmacy. This is the highest honor bestowed by the association. Nominee’s Name: _________________________________________ Workplace: ________________________________

bowl of hygeia award

Sponsored by Pfizer, the Bowl of Hygeia recognizes pharmacists who possess outstanding records of civic leadership in their own communities, from which their specific identification as a pharmacist reflects well on the profession. Nominee’s Name: _________________________________________ Workplace: ________________________________

distinguished young pharmacist award

Sponsored by Pharmacists Mutual Companies, the Distinguished Young Pharmacist Award recognizes a young pharmacist within his/ her first ten years of practice who has distinguished himself/herself in the field of pharmacy. This pharmacist is also a participant in national pharmacy associations, professional programs, state association activities and/or community service. Nominee’s Name: _________________________________________ Workplace: ________________________________

excellence in Innovation award

Sponsored by Upsher-Smith Laboratories, Inc., the Excellence in Innovation Award recognizes innovative pharmacy practice resulting in improved patient care. Nominee’s Name: _________________________________________ Workplace: ________________________________

Pharmacy Technician award

Presented by MPhA, the Pharmacy Technician Award recognizes a pharmacy technician in any practice setting who demonstrates leadership in their work and in their community. This includes demonstrating professionalism by participation in pharmacy association, professional programs and/or community service, promoting teamwork within the pharmacy, providing leadership and serving as a role model for coworkers, developing or assisting development of efficient safe procedures that support the provision of pharmaceutical care. Nominee’s Name: _________________________________________ Workplace: ________________________________

Recognizing members who are an inspiration to the field of pharmacy!

Nominator’s information: Name (please print): __________________________________________________________________________ Phone: ____________________________ E-mail: ______________________________________________ Address:_________________________________________________________________________________ City: ______________________________________________ state: _________ Zip: _________________

Please return all nominations by March 15, 2012 to the MPhA office.

Minnesota Pharmacist Winter 2012 n

Minnesota Pharmacist Winter 2012

7. Return abstract by: Thurday, May 3, 2012 to the MPhA office to Julie@mpha.org or fax: 651-290-2266

abstract, contact Todd Sorensen, PharmD. Associate Professor, College of Pharmacy, University of Minnesota, soren042@umn.edu

6. If you have questions about writing an

sent to this address)

5. E-mail address of contact person (notification of receipt and acceptance will be

4. A 4’x 8’ Velcro Board will be provided for poster presentations. A 6’ table will be provided only if requested by May 3, 2012. Electrical hookup is not available for poster presentations.

(*You must bring your own laptop or a flash drive for file transfer)

3. Visual Aids needed, if platform  LCD projector*

2. Abstract should contain:  Statement of purpose  Methodology  Results and discussion  Conclusion

1. Entire abstract in one paragraph with no margins. INDENT 4 spaces for first line. No less than 10-pitch type. Stay within borders!

Format for Abstract

 poster presentation

 to be determined by committee

* Please indicate designation of author(s), e.g., R.Ph., PharmD, etc.

Title:

Full name(s) of author(s)*, institution and address of corresponding author:

 platform presentation

MINNESOTA PHARMACISTS ASSOCIATION 128th ANNUAL CONFERENCE June 9, 2012

ABSTRACT

Pharmacy Professionals for Political Action What is PharmPAC? PharmPAC is a legal, transparent, state monitored, bi-partisan Political Action Committee (PAC) whose major purpose is to influence the nomination or election of a candidate who supports the profession of pharmacy and pharmacists. PharmPAC is a means to express united interests with one powerful voice. It is power in numbers. How does PharmPAC influence the political process? PharmPAC solicits contributions from individual pharmacists and pharmacy technicians in Minnesota and combines them to make larger contributions to candidates and party units. PharmPAC funds are also used to attend fundraiser events for candidates and party units. Who can receive PharmPAC funds? Candidates and incumbents who run for state office in Minnesota may receive PharmPAC funds. House of Representative members, Senators, the Governor, Secretary of State, Attorney General or any other state candidate who promotes and supports pharmacy can receive PAC funds. Which funds are accepted by PharmPAC? Individual contributions are accepted, but corporate contributions are prohibited. For each contribution over $20.00 a record of the donor will be kept. Anonymous contributions can not be accepted by PharmPAC. Other political committees, political funds or political party units registered in MN may also contribute to PharmPAC. Is PharmPAC regulated? PharmPAC is regulated by the Minnesota Campaign Finance Board. The state of Minnesota has some of the most strict campaign finance laws in the nation. All information from PharmPAC, other PACs and party units is recorded and filed with the Board. This information is available to the public at www.cfboard.state.mn.us Are there limits to how much a person can contribute? An individual may contribute unlimited amounts to PharmPAC. But PharmPAC is limited as to how much it can contribute to candidates and party units. How does PharmPAC determine who to contribute to? Contributions are determined with recommendations by the Chair, Treasurer, Deputy Treasurer, the Volunteer Committee, contributors, and others. Contributions are given to candidates or elected officials who are determined to be pharmacy friendly in a nonpartisan manner. Factors used to determine “pharmacy friendly” include but are not limited to: • Elected officials who have sponsored or authored legislation for pharmacists or pharmacy. • Chair persons of committees which deliberate issues relevant to pharmacy. • Elected officials who made difficult votes in favor of pharmacy initiatives. • Elected officials who attend or speak at pharmacy events. • Elected officials or challengers who pledge support and demonstrate 28

Minnesota Pharmacist Winter 2012 n

Contributions play a significant role in electing and supporting pharmacy friendly legislators who understand the importance of pharmacies and pharmacists. These legislators are willing to author bills we need and vote for our issues in committee meetings and in legislative sessions. PharmPAC funds help make the Legislature as pharmacy-friendly and pharmacy-knowledgeable as it can be.

willingness to sponsor pharmacy initiatives. • Caucus contributions are determined based on how many candidates or officials from the caucus attend the event, timing and effectiveness of contribution amount. What are the guidelines PharmPAC uses to disperse funds? Recommendations on which candidates are made by those most involved with the political process, ie lobbyists and PAC volunteers, Chair or Vice Chair who lobby or have legislative and campaign experience. Contributions are disbursed in a non-partisan manner. The qualification is “pharmacy friendly” not party friendly. Persons who shall receive preference when determining contributions, or ways to define “pharmacy friendly”: • Elected officials who have sponsored or authored legislation for pharmacists or pharmacy. • Chair persons of committees which deliberate issues relevant to pharmacy. • Elected officials who made difficult votes in favor of pharmacy initiatives. • Elected officials who attend and speak at pharmacy events. • Elected officials or challengers who pledge support and demonstrate willingness to sponsor pharmacy initiatives. Why have a PAC? PACs are an important part of the American political process. They have been around since 1944, when the Congress of Industrial Organizations (CIO) formed the first one to raise money for the re-election of President Franklin D. Roosevelt. PharmPAC is another way the profession of pharmacy maintains its presence in a crowded arena of special interests in the state’s political process. What’s in it for me? PharmPAC is an exciting way to be directly involved in the political process. Being involved with PharmPAC enables you to affect your professional livelihood in a powerful, positive way. By contributing to PharmPAC you will receive information about candidates and events in your area. You will know who supports your professional interests at the Minnesota state legislature. You will be a part of influencing the political process.

minnesota senators

Senate Floor ©Bill Nau

Capitol 75 Rev. Dr. Martin Luther King Jr. Blvd. Room (See numbers across) St. Paul, MN 55155-1606 State Office Building 100 Rev. Dr. Martin Luther King Jr. Blvd. Room (See numbers across) St. Paul, MN 55155-1206

www.senate.leg.state.mn.us • Find your district • Find your senator • Learn about your senator • Contact/email your senator If you don’t know what district you are in, visit the Minnesota Senate Web site to find out who represents you.

Name Bakk, Thomas M. Benson, Michelle R. Bonoff, Terri E. Brown, David M. Carlson, John Chamberlain, Roger C. Cohen, Richard J. Dahms, Gary H. Daley, Theodore J. “Ted” DeKruif, Al Dibble, D. Scott Dziedzic, Kari Eaton, Chris A. Fischbach, Michelle L. Gazelka, Paul E. Gerlach, Chris Gimse, Joe Goodwin, Barb J. Hall, Dan D. Hann, David W. Harrington, John M. Hayden, Jeff Higgins, Linda Hoffman, Gretchen M. Howe, John Ingebrigtsen, Bill Jungbauer, Michael J. Kelash, Kenneth S. Koch, Amy T. Kruse, Benjamin A. Kubly, Gary W. Langseth, Keith Latz, Ron Lillie, Ted H. Limmer, Warren Lourey, Tony Magnus, Doug Marty, John McGuire, Mary Jo Metzen, James P. Michel, Geoff Miller, Jeremy R. Nelson, Carla J. Newman, Scott J. Nienow, Sean R. Olson, Gen Ortman, Julianne E. Pappas, Sandra L. Parry, Mike Pederson, John C. Reinert, Roger J. Rest, Ann H. Robling, Claire A. Rosen, Julie A. Saxhaug, Tom Senjem, David H. Sheran, Kathy Sieben, Katie Skoe, Rod Sparks, Dan Stumpf, LeRoy A. Thompson, Dave Tomassoni, David J. Torres Ray, Patricia Vandeveer, Ray Wiger, Charles W. Wolf, Pam

Party Dist Rm Building Phone Email DFL 6 147 State 296-8881 Use Mail Form R 49 G-24 Capitol 296-3219 sen.michelle.benson@senate.mn DFL 43 133 State 296-4314 sen.terri.bonoff@senate.mn R 16 205 Capitol 296-8075 sen.david.brown@senate.mn R 4 320 Capitol 296-4913 sen.john.carlson@senate.mn R 53 306 Capitol 296-1253 sen.roger.chamberlain@senate.mn DFL 64 109 State 296-5931 Use Mail Form R 21 111 Capitol 296-8138 sen.gary.dahms@senate.mn R 38 G-24 Capitol 297-8073 sen.ted.daley@senate.mn R 25 G-24 Capitol 296-1279 sen.al.dekruif@senate.mn DFL 60 115 State 296-4191 sen.scott.dibble@senate.mn DFL 59 27 State 296-7809 sen.kari.dziedzic@senate.mn DFL 46 21 State 296-8869 Use Mail Form R 14 226 Capitol 296-2084 sen.michelle.fischbach@senate.mn R 12 325 Capitol 296-4875 sen.paul.gazelka@senate.mn R 37 120 Capitol 296-4120 sen.chris.gerlach@senate.mn R 13 303 Capitol 296-3826 sen.joe.gimse@senate.mn DFL 50 123 State 296-4334 sen.barb.goodwin@senate.mn R 40 325 Capitol 296-5975 sen.dan.hall@senate.mn R 42 328 Capitol 296-1749 Use Mail Form DFL 67 17 State 296-5285 sen.john.harrington@senate.mn DFL 61 151 State 296-4261 sen.jeff.hayden@senate.mn DFL 58 113 State 296-9246 sen.linda.higgins@senate.mn R 10 124 Capitol 296-5655 sen.gretchen.hoffman@senate.mn R 28 323 Capitol 296-4264 sen.john.howe@senate.mn R 11 303 Capitol 297-8063 sen.bill.ingebrigtsen@senate.mn R 48 235 Capitol 296-3733 sen.mike.jungbauer@senate.mn DFL 63 129 State 297-8061 sen.kenneth.kelash@senate.mn R 19 322 Capitol 296-5981 sen.amy.koch@senate.mn R 47 124 Capitol 296-4154 sen.benjamin.kruse@senate.mn DFL 20 103 State 296-5094 sen.gary.kubly@senate.mn DFL 9 139 State 296-3205 Use Mail Form DFL 44 121 State 297-8065 sen.ron.latz@senate.mn R 56 124 Capitol 296-4166 sen.ted.lillie@senate.mn R 32 122 Capitol 296-2159 sen.warren.limmer@senate.mn DFL 8 125 State 296-0293 sen.tony.lourey@senate.mn R 22 205 Capitol 296-5650 sen.doug.magnus@senate.mn DFL 54 119 State 296-5645 Use Mail Form DFL 66 23 State 296-5537 Use Mail Form DFL 39 15 State 296-4370 sen.jim.metzen@senate.mn R 41 208 Capitol 296-6238 sen.geoff.michel@senate.mn R 31 320 Capitol 296-5649 sen.jeremy.miller@senate.mn R 30 111 Capitol 296-4848 sen.carla.nelson@senate.mn R 18 301 Capitol 296-4131 sen.scott.newman@senate.mn R 17 120 Capitol 296-5419 sen.sean.nienow@senate.mn R 33 235 Capitol 296-1282 sen.gen.olson@senate.mn R 34 120 Capitol 296-4837 sen.julianne.ortman@senate.mn DFL 65 143 State 296-1802 Use Mail Form R 26 309 Capitol 296-9457 sen.mike.parry@senate.mn R 15 G-24 Capitol 296-6455 sen.john.pederson@senate.mn DFL 7 149 State 296-4188 sen.roger.reinert@senate.mn DFL 45 105 State 296-2889 Use Mail Form R 35 226 Capitol 296-4123 sen.claire.robling@senate.mn R 24 317 Capitol 296-5713 sen.julie.rosen@senate.mn DFL 3 135 State 296-4136 sen.tom.saxhaug@senate.mn R 29 121 Capitol 296-3903 sen.david.senjem@senate.mn DFL 23 127 State 296-6153 sen.kathy.sheran@senate.mn DFL 57 117 State 297-8060 sen.katie.sieben@senate.mn DFL 2 107 State 296-4196 sen.rod.skoe@senate.mn DFL 27 19 State 296-9248 sen.daniel.sparks@senate.mn DFL 1 145 State 296-8660 Use Mail Form R 36 323 Capitol 296-5252 sen.dave.thompson@senate.mn DFL 5 25 State 296-8017 sen.david.tomassoni@senate.mn DFL 62 131 State 296-4274 sen.patricia.torres.ray@senate.mn R 52 328 Capitol 296-4351 sen.ray.vandeveer@senate.mn DFL 55 141 State 296-6820 sen.chuck.wiger@senate.mn R 51 306 Capitol 296-2556 sen.pam.wolf@senate.mn

Minnesota Pharmacist Winter 2012 n

minnesota house of representatives

Capitol ©Bill Nau

State Office Building 100 Rev. Dr. Martin Luther King Jr. Blvd. Room (See numbers across) St. Paul, MN 55155-1206

www.house.leg.state.mn.us • Find your district • Find your representative • Learn about your representative • Contact/email your representative If you don’t know what district you are in, visit the Minnesota House Web site to find out who represents you.

Name Abeler, Jim Allen, Susan Anderson, Bruce Anderson, Sarah Anderson, Paul Anderson, Diane Anzelc, Tom Atkins, Joe Banaian, King Barrett, Bob Beard, Michael Benson, John Benson, Mike Bills, Kurt Brynaert, Kathy Buesgens, Mark Carlson Sr., Lyndon Champion, Bobby Joe Clark, Karen Cornish, Tony Crawford, Roger Daudt, Kurt Davids, Greg Davnie, Jim Dean, Matt Dettmer, Bob Dill, David Dittrich, Denise Doepke, Connie Downey, Keith Drazkowski, Steve Eken, Kent Erickson, Sondra Fabian, Dan Falk, Andrew Franson, Mary Fritz, Patti Garofalo, Pat Gauthier, Kerry Gottwalt, Steve Greene, Marion Greiling, Mindy Gruenhagen, Glenn Gunther, Bob Hackbarth, Tom Hamilton, Rod Hancock, David Hansen, Rick Hausman, Alice Hilstrom, Debra Hilty, Bill Holberg, Mary Liz Hoppe, Joe Hornstein, Frank Hortman, Melissa Hosch, Larry Howes, Larry Huntley, Thomas Johnson, Sheldon Kahn, Phyllis Kath, Kory Kelly, Tim Kieffer, Andrea Kiel, Debra Kiffmeyer, Mary Knuth, Kate Koenen, Lyle Kriesel, John Laine, Carolyn Lanning, Morrie Leidiger, Ernie

Minnesota Pharmacist Winter 2012 n

Party Dist Rm Office Phone Email R 48B 479 651-296-1729 rep.jim.abeler@house.mn DFL 61B 389 651-296-7152 rep.susan.allen@house.mn R 19A 365 651-296-5063 rep.bruce.anderson@house.mn R 43A 549 651-296-5511 rep.sarah.anderson@house.mn R 13A 445 651-296-4317 rep.paul.anderson@house.mn R 38A 525 651-296-3533 rep.diane.anderson@house.mn DFL 03A 307 651-296-4936 rep.tom.anzelc@house.mn DFL 39B 209 651-296-4192 rep.joe.atkins@house.mn R 15B 411 651-296-6612 rep.king.banaian@house.mn R 17B 413 651-296-5377 rep.bob.barrett@house.mn R 35A 417 651-296-8872 rep.mike.beard@house.mn DFL 43B 289 651-296-9934 rep.john.benson@house.mn R 30B 515 651-296-4378 rep.mike.benson@house.mn R 37B 533 651-296-4306 rep.kurt.bills@house.mn DFL 23B 327 651-296-3248 rep.kathy.brynaert@house.mn R 35B 381 651-296-5185 rep.mark.buesgens@house.mn DFL 45B 283 651-296-4255 rep.lyndon.carlson@house.mn DFL 58B 329 651-296-8659 rep.bobby.champion@house.mn DFL 61A 277 651-296-0294 rep.karen.clark@house.mn R 24B 437 651-296-4240 rep.tony.cornish@house.mn R 08B 421 651-296-0518 rep.roger.crawford@house.mn R 17A 487 651-296-5364 rep.kurt.daudt@house.mn R 31B 585 651-296-9278 rep.greg.davids@house.mn DFL 62A 215 651-296-0173 rep.jim.davnie@house.mn R 52B 459 651-296-3018 rep.matt.dean@house.mn R 52A 473 651-296-4124 rep.bob.dettmer@house.mn DFL 06A 273 651-296-2190 rep.david.dill@house.mn DFL 47A 311 651-296-5513 rep.denise.dittrich@house.mn R 33B 579 651-296-4315 rep.connie.doepke@house.mn R 41A 407 651-296-4363 rep.keith.downey@house.mn R 28B 401 651-296-2273 rep.steve.drazkowski@house.mn DFL 02A 243 651-296-9918 rep.kent.eken@house.mn R 16A 509 651-296-6746 rep.sondra.erickson@house.mn R 01A 431 651-296-9635 rep.dan.fabian@house.mn DFL 20A 239 651-296-4228 rep.andrew.falk@house.mn R 11B 429 651-296-3201 rep.mary.franson@house.mn DFL 26B 253 651-296-8237 rep.patti.fritz@house.mn R 36B 537 651-296-1069 rep.pat.garofalo@house.mn DFL 07B 225 651-296-4246 rep.kerry.gauthier@house.mn R 15A 485 651-296-6316 rep.steve.gottwalt@house.mn DFL 60A 331 651-296-0171 rep.marion.greene@house.mn DFL 54A 393 651-296-5387 rep.mindy.greiling@house.mn R 25A 575 651-296-4229 rep.glenn.gruenhagen@house.mn R 24A 591 651-296-3240 rep.bob.gunther@house.mn R 48A 409 651-296-2439 rep.tom.hackbarth@house.mn R 22B 559 651-296-5373 rep.rod.hamilton@house.mn R 02B 529 651-296-4265 rep.david.hancock@house.mn DFL 39A 247 651-296-6828 rep.rick.hansen@house.mn DFL 66B 255 651-296-3824 rep.alice.hausman@house.mn DFL 46B 261 651-296-3709 rep.debra.hilstrom@house.mn DFL 08A 207 651-296-4308 rep.bill.hilty@house.mn R 36A 453 651-296-6926 rep.maryliz.holberg@house.mn R 34B 563 651-296-5066 rep.joe.hoppe@house.mn DFL 60B 213 651-296-9281 rep.frank.hornstein@house.mn DFL 47B 377 651-296-4280 rep.melissa.hortman@house.mn DFL 14B 349 651-296-4373 rep.larry.hosch@house.mn R 04B 491 651-296-2451 rep.larry.howes@house.mn DFL 07A 351 651-296-2228 rep.thomas.huntley@house.mn DFL 67B 217 651-296-4201 rep.sheldon.johnson@house.mn DFL 59B 353 651-296-4257 rep.phyllis.kahn@house.mn DFL 26A 201 651-296-5368 rep.kory.kath@house.mn R 28A 565 651-296-8635 rep.tim.kelly@house.mn R 56B 531 651-296-1147 rep.andrea.kieffer@house.mn R 01B 423 651-296-5091 rep.deb.kiel@house.mn R 16B 501 651-296-4237 rep.mary.kiffmeyer@house.mn DFL 50B 323 651-296-0141 rep.kate.knuth@house.mn DFL 20B 241 651-296-4346 rep.lyle.koenen@house.mn R 57A 451 651-296-4342 rep.john.kriesel@house.mn DFL 50A 287 651-296-4331 rep.carolyn.laine@house.mn R 09A 379 651-296-5515 rep.morrie.lanning@house.mn R 34A 415 651-296-4282 rep.ernie.leidiger@house.mn

minnesota house of representatives Name LeMieur, Mike Lenczewski, Ann Lesch, John Liebling, Tina Lillie, Leon Loeffler, Diane Lohmer, Kathy Loon, Jenifer Mack, Tara Mahoney, Tim Mariani, Carlos Marquart, Paul Mazorol, Pat McDonald, Joe McElfatrick, Carolyn McFarlane, Carol McNamara, Denny Melin, Carly Moran, Rena Morrow, Terry Mullery, Joe Murdock, Mark Murphy, Erin Murphy, Mary Murray, Rich Myhra, Pam Nelson, Michael V. Nornes, Bud Norton, Kim Oâ&#x20AC;&#x2122;Driscoll, Tim Paymar, Michael Pelowski Jr., Gene Peppin, Joyce Persell, John Petersen, Branden Peterson, Sandra Poppe, Jeanne Quam, Duane Rukavina, Tom Runbeck, Linda Sanders, Tim Scalze, Bev Schomacker, Joe Scott, Peggy Shimanski, Ron Simon, Steve Slawik, Nora Slocum, Linda Smith, Steve Stensrud, Kirk Swedzinski, Chris Thissen, Paul Tillberry, Tom Torkelson, Paul Urdahl, Dean Vogel, Bruce Wagenius, Jean Ward, John Wardlow, Doug Westrom, Torrey Winkler, Ryan Woodard, Kelby Zellers, Kurt

Party Dist Rm Office Phone Email R 12B 567 651-296-4247 rep.mike.lemieur@house.mn DFL 40B 317 651-296-4218 rep.ann.lenczewski@house.mn DFL 66A 315 651-296-4224 rep.john.lesch@house.mn DFL 30A 357 651-296-0573 rep.tina.liebling@house.mn DFL 55A 281 651-296-1188 rep.leon.lillie@house.mn DFL 59A 335 651-296-4219 rep.diane.loeffler@house.mn R 56A 521 651-296-4244 rep.kathy.lohmer@house.mn R 42B 403 651-296-7449 rep.jenifer.loon@house.mn R 37A 557 651-296-5506 rep.tara.mack@house.mn DFL 67A 237 651-296-4277 rep.tim.mahoney@house.mn DFL 65B 203 651-296-9714 rep.carlos.mariani@house.mn DFL 09B 313 651-296-6829 rep.paul.marquart@house.mn R 41B 581 651-296-7803 rep.pat.mazorol@house.mn R 19B 523 651-296-4336 rep.joe.mcdonald@house.mn R 03B 545 651-296-2365 rep.carolyn.mcelfatrick@house.mn R 53B 597 651-296-5363 rep.carol.mcfarlane@house.mn R 57B 375 651-296-3135 rep.denny.mcnamara@house.mn DFL 05B 309 651-296-0172 rep.carly.melin@house.mn DFL 65A 227 651-296-5158 rep.rena.moran@house.mn DFL 23A 211 651-296-8634 rep.terry.morrow@house.mn DFL 58A 387 651-296-4262 rep.joe.mullery@house.mn R 10B 593 651-296-4293 rep.mark.murdock@house.mn DFL 64A 345 651-296-8799 rep.erin.murphy@house.mn DFL 06B 343 651-296-2676 rep.mary.murphy@house.mn R 27A 439 651-296-8216 rep.rich.murray@house.mn R 40A 517 651-296-4212 rep.pam.myhra@house.mn DFL 46A 229 651-296-3751 rep.michael.nelson@house.mn R 10A 471 651-296-4946 rep.bud.nornes@house.mn DFL 29B 233 651-296-9249 rep.kim.norton@house.mn R 14A 369 651-296-7808 rep.tim.odriscoll@house.mn DFL 64B 301 651-296-4199 rep.michael.paymar@house.mn DFL 31A 295 651-296-8637 rep.gene.pelowski@house.mn R 32A 503 651-296-7806 rep.joyce.peppin@house.mn DFL 04A 223 651-296-5516 rep.john.persell@house.mn R 49B 577 651-296-5369 rep.branden.petersen@house.mn DFL 45A 337 651-296-4176 rep.sandra.peterson@house.mn DFL 27B 291 651-296-4193 rep.jeanne.poppe@house.mn R 29A 569 651-296-9236 rep.duane.quam@house.mn DFL 05A 303 651-296-0170 rep.tom.rukavina@house.mn R 53A 583 651-296-2907 rep.linda.runbeck@house.mn R 51A 449 651-296-4226 rep.tim.sanders@house.mn DFL 54B 259 651-296-7153 rep.bev.scalze@house.mn R 22A 433 651-296-5505 rep.joe.schomacker@house.mn R 49A 477 651-296-4231 rep.peggy.scott@house.mn R 18A 367 651-296-1534 rep.ron.shimanski@house.mn DFL 44A 279 651-296-9889 rep.steve.simon@house.mn DFL 55B 245 651-296-7807 rep.nora.slawik@house.mn DFL 63B 359 651-296-7158 rep.linda.slocum@house.mn R 33A 543 651-296-9188 rep.steve.smith@house.mn R 42A 553 651-296-3964 rep.kirk.stensrud@house.mn R 21A 527 651-296-5374 rep.chris.swedzinski@house.mn DFL 63A 267 651-296-5375 rep.paul.thissen@house.mn DFL 51B 231 651-296-5510 rep.tom.tillberry@house.mn R 21B 371 651-296-9303 rep.paul.torkelson@house.mn R 18B 571 651-296-4344 rep.dean.urdahl@house.mn R 13B 507 651-296-6206 rep.bruce.vogel@house.mn DFL 62B 251 651-296-4200 rep.jean.wagenius@house.mn DFL 12A 221 651-296-4333 rep.john.ward@house.mn R 38B 551 651-296-4128 rep.doug.wardlow@house.mn R 11A 443 651-296-4929 rep.torrey.westrom@house.mn DFL 44B 321 651-296-7026 rep.ryan.winkler@house.mn R 25B 539 651-296-7065 rep.kelby.woodard@house.mn R 32B 463 651-296-5502 rep.kurt.zellers@house.mn

my district:

my representative:

notes:

Minnesota Pharmacist Winter 2012 n

united states Minnesota house & senate

Please note that mail delivery to Washington can be delayed by up to 10 days due to security screening. If your message is urgent, fax your letter to Washington, contact their district office, or send an email through their Web site. Congressman timothy Walz First Congressional District of Minnesota http://walz.house.gov • Washington, DC 1529 Longworth House Office Building Washington, DC 20515 • 202-225-2472 • Rochester 1134 7th Street NW Rochester, MN 55901 • 507-206-0643 • Mankato 227 Main Street E, #220 Mankato, MN 56001 • 507-388-2149 Congressman John Kline Second Congressional District of Minnesota http://kline.house.gov • Washington, DC 1429 Longworth House Office Building Washington, DC 20515 202-225-2271 • 202-225-2595 fax • Burnsville 101 West Burnsville Pkwy., Ste. #201 Burnsville, MN 55337 • 952-808-1213 Congressman eric paulsen Third Congressional District of Minnesota http://paulsen.house.gov • Washington, DC 126 Cannon House Office Building Washington, DC 20515 202-225-2871 • 202-225-6351 fax • eden prairie 250 Prairie Center Drive, Suite 230 Eden Prairie, MN 55344 • 952-405-8510 Congresswoman Betty McCollum Fourth Congressional District of Minnesota http://www.mccollum.house.gov • Washington, DC 1714 Longworth House Office Building Washington, DC 20515 202-225-6631 • 202-225-1968 fax • Saint Paul 165 Western Avenue N, Suite 17 St. Paul, MN 55102 • 651-224-9191 Congressman keith ellison Fifth Congressional District of Minnesota • Washington, DC 1130 Longworth House Office Building Washington, DC 20515 202-225-4755 • 202-225-4886 fax • Minneapolis 2100 Plymouth Avenue N Minneapolis, MN 55411 • 612-522-1212 32

Minnesota Pharmacist Winter 2012 n

Congresswoman Michele Bachmann Sixth Congressional District of Minnesota http://bachmann.house.gov • Washington, DC 412 Cannon HOB Washington, DC 20515 202-225-2331 • 202-225-6475 fax • Woodbury 6043 Hudson Road, Suite 330 Woodbury, MN 55125 • 651-731-5400 • St. Cloud/Waite Park 110 2nd Street S, Suite 232 Waite Park, MN 56387 • 320-253-5931

senator Amy Klobuchar http://klobuchar.senate.gov

Congressman Collin Peterson Seventh Congressional District of Minnesota http://collinpeterson.house.gov • WASHINGTON, DC 2211 Rayburn HOB Washington, DC 20515 202-225-2165 • 202-225-1593 fax • Detroit Lakes 714 Lake Avenue, Suite 107 Detroit Lakes, MN 56501 • 218-847-5056 • Marshall 1420 East College Drive, SW/WC Marshall, MN 56258 • 507-537-2299 • Montevideo 100 First Street N Montevideo, MN 56265 • 320-269-8888 • Red Lake Falls MN Wheat Growers Building 2603 Wheat Drive Red Lake Falls, MN 56750 • 218-253-4356 • Redwood Falls 230 East 3rd Street, P.O. Box 50 Redwood Falls, MN 56283 • 507-637-2270 • Willmar 320 4th St SW, Centre Point Mall Willmar, MN 56201 • 320-235-1061

• Moorhead 121 4th Street S Moorhead, MN 56560 • 218-287-2219

Congressman Chip cravaack Eighth Congressional District of Minnesota http://chipcravaack.house.gov • WASHINGTON, DC 508 Cannon HOB Washington, DC 20515 202-225-6211 • 202-225-0699 fax • NORTH BRANCH 6448 Main St., Suite Ste 6 North Branch, Minnesota 55056 • 651-237-8220 or 1-888-563-7390 Fax: 651-237-8225

• Washington, DC 302 Hart Office Building Washington, DC 20510 202-224-3244 • 202-228-2186 fax • Metro 1200 Washington Avenue S, Suite 250 Minneapolis, MN 55415 • 612-727-5220 • Rochester 1134 7th Street NW Rochester, MN 55901 • 507-288-5321

• Iron Range Olcott Plaza, Suite 105 820 9th Street N Virginia, MN 55792 • 218-741-9690 senator al franken http://franken.senate.gov • Washington, DC 320 Hart Senate Office Building Washington, DC 20510 • 202-224-5641 • st paul 60 East Plato Blvd, Suite 220 Saint Paul, MN 55107 • 651-221-1016 • saint peter 208 S Minnesota Ave., Suite 6 Saint Peter, MN 56082 • 507-931-7345 • saint cloud 916 W St. Germain St., Suite 110 Saint Cloud, MN 56301 • 320-251-2721 • duluth 515 W 1st St., Suite 104 Duluth, MN 55082 • 218-722-2390

minnesota pharmacy resources university of minnesota College of Pharmacy

College of Pharmacy University of Minnesota 5-130 Weaver-Densford Hall 308 Harvard Street SE Minneapolis, MN 55455 612-624-1900 612-624-2974 fax www.pharmacy.umn.edu

Dean Marilyn K. Speedie, Ph.D. 612-624-1900

university of minnesota College of Pharmacy, duluth

University of Minnesota College of Pharmacy, Duluth 386 Kirby Plaza 1208 Kirby Drive Duluth, MN 55812-3095 218-726-6000 218-726-6500 fax www.pharmacy.umn.edu/duluth

minnesota board of pharmacy

The Minnesota Board of Pharmacy (BOP) exists to protect the public from adulterated, misbranded, and illicit drugs, and from unethical or unprofessional conduct on the part of pharmacists or other licensees, and to provide a reasonable assurance of professional competency in the practice of pharmacy by enforcing the Pharmacy Practice Act M.S. 151, State Controlled Substances Act M.S. 152 and various other statutes. The board strives to fulfill its mission through a combination of regulatory activity, technical consultation and support for pharmacy practices through the issuance of advisories on pharmacy practice issues, and through education of pharmacy practitioners. The Board of Pharmacy consists of seven board members, appointed by the governor; five board members must be pharmacists, and two members must be public members. The board regulates pharmacists, pharmacies, pharmacy technicians, controlled substance researchers, drug wholesalers and drug manufacturers. The board approves licenses or registrations for these individuals or businesses, and also decides when to impose disciplinary action. Minnesota Board of Pharmacy Cody C. Wiberg, Executive Director 2829 University Ave, SE, Suite 530 Minneapolis, MN 55414 651-201-2825 651-201-2837 fax 800-627-3529 hearing impaired www.phcybrd.state.mn.us

Minnesota Board of Pharmacy Members President: James Koppen Vice President: Laura J. Schwartzwald Pharmacist Members: Karen Bergrud, Bob Goetz, Kay Hanson Public Members: Ikram–ul–Huq, Stuart Williams

minnesota department of human services

The Minnesota Department of Human Services (DHS) helps people meet their basic needs by providing or administering health care coverage, economic assistance, and a variety of services for children, people with disabilities and older Minnesotans. DHS programs include Medical Assistance (MA), MinnesotaCare, Minnesota Family Investment Program (Minnesota’s version of the federal Temporary Assistance for Needy Families program), General Assistance (GA), the Prescription Drug Program, child protection, child support enforcement, child welfare services, and services for people who are mentally ill, chemically dependent or have physical or developmental disabilities. www.dhs.state.mn.us Drug Utilization Review board (DUR) The Drug Utilization Review Board (DUR) selects specific drug entities or therapeutic classes to be targeted for provider and recipient educational interventions, and provides guidelines for their use. The DUR board is comprised of four licensed physicians, at least three licensed pharmacists and one consumer representative, with the remaining members being licensed health care professionals with clinically appropriate knowledge in prescribing, dispensing, and monitoring outpatient drugs. DUR board meetings are held four times a year. Appointing authority: Commissioner of Human Services. Compensation: $50 per member per meeting plus mileage. (Minnesota Statutes 256B.0625, subd. 13a) Drug Formulary Committee (DFC) The Drug Formulary Committee (DFC) is charged with reviewing and recommending which drugs require authorization. The DFC also reviews drugs for which coverage is optional under federal and state law. (For possible inclusion in the Medicaid fee-for-service formulary.) The DFC is comprised of four physicians, at least three pharmacists, a consumer representative, and knowledgeable health care professionals. DFC meetings are open to the public and public comments are taken for an additional 30 days following a DFC recommendation to require prior authorization for a drug. The Department of Human Services provides the DFC with information regarding the impact that placing a drug on authorization will have on the quality and cost of patient care. Appointing authority: Commissioner of Human Services. Compensation: None. (Minnesota Statutes 256B.0625, subd. 13)

Minnesota Pharmacist Winter 2012 n

2012 MPha award categories recognize those making a difference in the profession of pharmacy. The association annually recognizes leaders in the field of pharmacy. Please help us identify pharmacy leaders by submitting a nomination form(s) and letters of support to the MPhA office. More information can be found on the MPhA Web site. Following are descriptions of each award, and past recipients, beginning with the most recent 2011 recipients. Harold r. popp award

Sponsored by the Minnesota Pharmacists Association, the Popp Award was established by MPhA in 1969 in honor of the late Senator Harold R. Popp to recognize one pharmacist annually for outstanding services to the profession of pharmacy. This is the highest honor bestowed by the association. This award is presented at the MPhA Annual Meeting. Rod Carter Marilyn Eelkema Randy Seifert Chris Koentopp Paul Iverson Dale Olson Steven Simenson Marilyn K. Speedie James Armbrustser John Stevens Herbert Whittemore Michael A. Kelly Marv Dyrstad Keith Pearson Julie K. Johnson

David Holmstrom Gary Raines Barb Jones Karl Leupold Gilbert Banker Howard Juni Doris Calhoun Donald P. Gibson S. Bruce Benson Gary Schneider Russ Boogren Carl Oberg Jr. Barry Krelitz Roland Leuzinger Lawrence C. Weaver

Lowell J. Anderson John H. Nelson Frank D. DiGangi Neal W. Schwartau Kendall B. Macho J. Roger Vadheim Kitty Alcott William Appel Russel F. King Charles V. Netz Henry M. Moen Arnold D. Delger John E. Quistgard

bowl of hygeia

Sponsored by Wyeth Pharmaceuticals, the Bowl of Hygeia recognizes pharmacists who possess outstanding records of civic leadership in their own communities, from which their specific identification as a pharmacist reflects well on the profession. This award is presented at the MPhA Annual Meeting. John Hoeschen Gregory Trumm Patricia Lind Gary Raines Vern Peterson Paul Iverson Brian Isetts Steven T. Simenson Richard C. Sundberg Terry L. Hartmann Sherwood Peterson, Jr. Julie K. Johnson Dale Olson John Stevens Mike Hart Howard Juni Robert Reutzel Robert Setzer

Chuck Frost Robert Warren Don Dinndorf Herb Whittemore James Alexander John H. Nelson Donald P. Gibson Brad Stanius Gary Schneider Richard Kienzle Harold McMahon Doris Calhoun Andrew Johnson Robert W. Foster Lowell J. Anderson Ronald O. Leuzinger Earl A. Schwerman Arnold D. Delger

Minnesota Pharmacist Winter 2012 n

Carl W. Oberg, Jr. Russell Boogren, Jr. Jack R. Andrews Frank E. DiGangi Roger Vadheim Russell F. King, Jr. Burton Magnuson Andrew G. Sanders Bernard H. Trygstad Willard J. Hadley Maynard L. Johnson Argyll W. Peterson William D. Nelson Orace Hanson Paul C. Anderson Arnold M. Grais Ted F. Maier

distinguished young pharmacist

Sponsored by Pharmacists Mutual Companies, the Distinguished Young Pharmacist Award recognizes a young pharmacist within his/her first ten years of practice who has distinguished himself/herself in the field of pharmacy. This pharmacist is also a participant in national pharmacy associations, professional programs, state association activities and/or community service. This award is presented at the MPhA Annual Meeting. Sarah Leslie Dan Rehrauer Julie Fike Sarah Westberg Stephanie Davis Michelle Aytay Mark Dewey Terry Hietpas Todd D. Sorensen

Michelle Johnson Debra Sisson Laura Odell Molly Ekstrand Denise Wolff Roger McDannold John Hoeschen Jason Varin Karen Schramm

Scott Benson Sherwood Peterson, Jr. Nancy Ruhland Mary Hayney Jeffrey Shapiro Lucy Johnson Kathryn Nygren

Excellence in Innovation

Sponsored by Upsher Smith, the Excellence in Innovation award recognizes innovative pharmacy practice resulting in improved patient care. This award is presented at the MPhA Annual Meeting. Camille Kundel Amanda Brummel Shannon Reidt Bruce Thompson Vyvy Vo April Hanson

Jeremy Johnson Daniel J. Rehrauer J.D. Anderson Tiffany D. Elton Ronald Hartmann Paul Iverson

Sherwood Peterson Jr. Peters Institute Laura Miller Tom Jackson John Loch Keith Pearson

PHARMACY TECHNICIAN AWARD

Presented by MPhA, the Pharmacy Technician Award recognizes a pharmacy technician in any practice setting who demonstrates leadership in their work and in their community. This includes demonstrating professionalism by participation in pharmacy association, professional programs and/or community service, promoting teamwork within the pharmacy, providing leadership and serving as a role model for coworkers, developing or assisting development of efficient safe procedures that support the provision of pharmaceutical care. This award is presented at the annual MPhA/MSHP Technician Conference. Robbin Leach Carole Lentz Tina Nathe

Jennifer Sandberg Sandra Christensen Cheryl Blegen

Jamie Jesnowski Heidi Miller

Please provide a letter of support for each award nominee describing in detail the reasons for the MPhA Awards Committee to consider your nominee. Include specific examples and/or details. Attach your nomination letter and any supporting documents to the form on page 26, including a current CV of nominee if possible. Nominations that do not include adequate information will not be considered until missing information is submitted. Nominators will be notified when nominations are received by the MPhA office and if additional information is required. Please see the MPhA Web site for additional award information and forms: www.mpha.org.

The Minnesota Pharmacists Foundation is an organization that invests in public health through the profession of pharmacy. The Minnesota Pharmacists Foundation formed in May 2003 to enhance patient care practices and the development of leadership opportunities for Minnesota pharmacists. The foundation promotes and communicates leading-edge practice innovations that consistently demonstrate improved patient outcomes.

Foundation GOALS: Create a strong future for pharmacy by investing in its pharmacists of tomorrow. Award annual scholarships to pharmacy students attending the University of Minnesota campuses in Duluth and Minneapolis. Support leadership training to potential Minnesota pharmacist leaders.

Foundation Activities: Created the AWARxE campaign to educate communities and individuals on the dangers of prescription medications. Hosts the annual Herbie Cup to raise money for the Herb and Addie Whittemore scholarship. Developed the Student Education Fund to invest in our future pharmacy leaders. Awards scholarships annually to pharmacy students at the University of Minnesota campuses in Duluth and Minneapolis. Helped bring the Meth Watch program to Minnesota to help educate consumers and retailers on meth awareness.

â&#x20AC;&#x153;We get closer to achieving our goals every day with your support...any level of support is appreciated.â&#x20AC;?

Minnesota Pharmacist Winter 2012 n

advertising:

minnesota pharmacist

quarterly journal The Minnesota Pharmacist is a quarterly journal publication of the Minnesota Pharmacists Association (MPhA) with a circulation of 1,800. The leading information resource for pharmacy in Minnesota, each journal includes in-depth articles on clinical, practice, industry, management and legislative issues. approval & placement: All advertising is subject to publisher’s approval. Acceptance of advertisement does not constitute endorsement, and is subject to space availability. To reserve space in an upcoming journal, submit an Advertising Purchase Request form by the indicated due date. Orders must be received before deadline to hold space. Please call ahead if you have deadline conflicts. Errors: The publisher shall not be liable for slight changes or typographical errors which do not lessen the value of the advertisement. The publisher shall not be liable for any other errors appearing in any advertisement unless the magazine received corrected copy before the issue deadline with corrections plainly noted. indemnification: All advertisements are accepted and published on the representation that the advertiser and/or the advertising agency are authorized to publish the entire contents and subject matter thereon, as confirmed by verbal or written order from the person representing the advertiser and/or advertising agency. The advertiser agrees to indemnify and hold the publisher and production company harmless from any and all liability, claims, demands or damages arising out of the advertising or on behalf of the advertiser. Such indemnity includes the provision of a defense to any actions or claims and the payment of cost and attorney’s fees in connection therewith. supplying files: Files may be emailed or mailed to the MPhA office. Preferred mailed formats: CD saved for MAC use. Preferred email formats: High/Press quality PDF with proper color separations. Accepted file formats: High/Press quality PDF, EPS, TIF, or JPEG (maximum quality). When supplying files other than PDF, you must include all original graphics used in file and all fonts used. Please ensure that your files color separate correctly.

spring - April • Advertising due March 15, 2012

summer - july • Advertising due June 15, 2012

fall - october • Advertising due September 14, 2012

Contact Anna Wrisky at the MPhA office for more information: annaw@ewald.com or 651-290-6298. • $100 frequency discount available on annual reservation (4 issues). • MPhA meeting exhibitors receive $100 advertising credit when placing an ad in the issue preceding the event. Signed exhibiting confirmation notice must be received by our office for discount to be effective.

Ad size and Rates Size Dimensions Black & White

CMYK

Full page

8.5 x 11

$740

$1,470

Half page

3.75 x 9.5 vertical 7.5 x 4.75 horizontal

$485 $485

$1,215 $1,215

Third page

2.9 x 9.5 vertical 7.5 x 3.125 horizontal

$430 $430

$1,160 $1,160

Fourth page

3.75 x 4.75 vertical 4.75 x 3.75 horizontal

$335 $335

$1,065 $1,065

Eighth page

2 x 3.5 vertical 3.5 x 2 horizontal

$200 $200

N/A N/A

Classified

over 75 words under 75 words

$50 $25

N/A N/A

minnesota pharmacist

2012 Editorial Calendar and submission dates The Leading Information Resource for Pharmacy in Minnesota Month/Issue Focus

Editorial Advertisement Deadline Deadline Mails

spring

Pharmacy Legislative Day Wrap Mid-Session Report

March 1

March 15

April

summer

PharmPAC Newsletter Annual Meeting Wrap Session Wrap House of Delegates Report New MPhA Board Members

May 31

June 15

July

fall

Fall Clinical Symposium Wrap Promote Pharmacy Legislative Day Award Nomination Forms

August 31

September 15

October

WINTER

Pharmacist Resource Guide

December 1

December 15

January Year in Review AWARxE Update

Every issue

President’s Desk Executive’s Report Public Affairs Feature articles MPhA featured member benefit Pharmacy & the Law/Financial Forum

Exhibitors are eligible for a discounted advertising rate for the issue promoting the event. The Minnesota Pharmacist is a quarterly journal publication of the Minnesota Pharmacists Association (MPhA). All advertising and feature articles are subject to publisher’s approval. Acceptance of advertisement or editorial content does not constitute endorsement, and is subject to space availability. MPhA welcomes editorial content that has a direct link to professional managment, growth or inititives in the pharmacy field. To be considered for publication, submit your name (along with any connections to a specific product or company) with a sample or explanation of your editorial content to Anna Wrisky at annaw@ewald.com or fax to 651-290-2266. Authors will be notified if their submissions are accepted for publication. All authors receive a complimentary copy of the issue containing their content.

Minnesota Pharmacist Winter 2012 n

spring - April • Advertising due March 15, 2012

summer - july • Advertising due June 15, 2012

fall - october • Advertising due September 14, 2012

advertising request form

minnesota pharmacist quarterly journal

Company Advertising: ______________________________________________________

issue: size: Mail or Fax to Anna Wrisky Minnesota Pharmacists Association 1000 Westgate Drive • Suite 252 St. Paul, MN 55114 651-697-1771 • 651-290-2266 fax • Tear sheets will be supplied with invoice or receipts to the billing address provided. • $100 frequency discount per issue on annual reservation (4 issues). • MPhA meeting exhibitors receive $100 advertising credit on orders when placed in the issue preceding the event. Signed exhibiting confirmation notice must be received by our office for discount to be effective. • Include yourself on our journal mailing list by becoming an Associate Member! Annual subscriptions of $100 are also available.

Winter Full

color:

Half

Spring Third

Summer

Fall

Fourth

Annual (4 issues)

Eighth

Black (Eighth and Classified are black only)

Classified: -75 / +75 Full Color

Spot Color

total advertising cost: $_______________________ billing:

Above Company

Advertising Agency

Firm: ___________________________________________________________________ Address: _________________________________________________________________ City: ___________________________________ State: ______ ZIP: _______________ Contact Person: ___________________________________________________________ Phone: ______________________________ Fax: _______________________________ E-mail: __________________________________________________________________

payment:

Invoice me

Check enclosed

Charge: MC / Visa / Amex / Discover

number:___________________________________________________________ expiration:______________ name on card:________________________________________________

3 or 4 digit code:______________

billing address:____________________________________________________________________________ city:______________________________________________ state:__________ zip:_____________________ signature:_________________________________________________________

_______________________

Invoice/ job number to reference (if applicable): ______________________ • Questions? Contact Anna Wrisky at the MPhA office: annaw@ewald. com or 651-290-6298.

This form will be used to secure space in MPhA’s 2012 journals and will act as an intent to purchase advertising. Name and Title (please print): ________________________________________________ Signature: _________________________________________________ Date: _________

Minnesota Pharmacist Winter 2012 n

Two Great Ways to Earn Rewards With McKesson and Pace Alliance Our dedication to your continued success as an independent pharmacy means making an impact on our industry, as well as your bottom line. That is why we’ve strengthened our relationship to deliver even greater value to McKesson Distribution customers who are members of Pace Alliance. Eligible customers now have the opportunity to earn up to 13% in an additional monthly rebate on net McKesson OneStop Generics® purchases, while implementing valuable businessbuilding solutions. Plus, as more Pace Alliance members become McKesson customers, the rebate percentages can get even higher.

Fewer Requirements, Bigger Rewards

Perform at Your Peak with Health Mart®

The Pace Performance Rewards program now provides even greater rewards based on your purchasing commitment. Not only have we enhanced the rebates, but we’ve eased the requirements. So all Pace members who use McKesson as their primary wholesaler and participate in the following valuable McKesson programs have an opportunity to earn greater rewards:

In addition to monthly rebates of up to 13% (or more) on qualified OneStop purchases, Health Mart pharmacies can earn up to $10,000 per year in technology rebates through the Pace Peak Performance Rewards program.1 Pace Peak Performance Rewards is available exclusively to Health Mart franchisees who participate in:

– McKesson’s Generics Purchasing Rewards Program – ASAP and ASAP Plus autoship programs SM

generics

– GenericsConnect , a regularly scheduled call from a dedicated generics specialist SM

– Controlled Substance Ordering System (CSOS)

– McKesson’s Generics Purchasing Rewards Program – ASAPSM and ASAP PlusSM generics autoship programs – GenericsConnectSM, a regularly scheduled call from a dedicated generics specialist – Controlled Substance Ordering System (CSOS) – AccessHealth® – McKesson Reimbursement Advantage

“By strengthening our partnership with McKesson, Pace Alliance can continue to focus on our advocacy efforts and deliver even greater value to our members.” Curtis J. Woods, R.Ph. President and CEO Pace Alliance

Pace and McKesson: A Complete Solution for Independent Pharmacy Since 1985, Pace Alliance has been working on behalf of independent community pharmacies to help them decrease costs, while generating revenue for state pharmacy organizations. Today, Pace is owned by 19 state pharmacy organizations and is dedicated to protecting and advancing the profession for community pharmacies nationwide. Together, Pace and McKesson are dedicated to helping community pharmacies thrive in today’s marketplace. As part of this continued commitment to your success, Pace members can benefit from McKesson’s revenue-building solutions and cost-reducing programs and services.

Every Customer counts! Dakota Drug Inc. 1101 Lund Boulevard Anoka, MN 55303 phone (763) 432-4333 fax (763) 421-0661 www.dakdrug.com

The

As the Midwestâ&#x20AC;&#x2122;s only Independent Drug Wholesaler, Dakota Drug has grown and developed by addressing the needs of you, the Community Pharmacist, and by providing assistance to ensure your success. We are committed to personal service and welcome the opportunity to assist you.

Upper Midwestâ&#x20AC;&#x2122;s Independent Healthcare Distributor